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SYNTHETIC ANALGESICS AND ANTISPASMODICS.
Introduction.
Analgesics are drugs which diminish or abolish 
the sensation of pain* Antispasmodics are drugs which 
relax the smooth (involuntary) muscle of the body and 
thereby relieve spasm, the violent, painful contraction 
of smooth muscle. Analgesics and antispasmodics are 
thu3 allied In manTs age-long fight against pain; and 
while little is known as yet of the manner in which these 
drugs produce their physiological effects they appear to 
be related chemically also, for many compounds possess 
both types of activity.
ANALGESICS.
The relief of pain has long been one of the prin­
cipal objectives of medicine, and of late the realisation 
of the harmful psychological and physiological effects of 
pain has added weight to the original, no doubt largely 
humane, reasons for seeking its alleviation.
Analgesics belong pharmacologically to the class 
of symptomatic drugs, having mainly a depressant effect 
on the central nervous system, although it is probable that
1 pthe autonomic nervous system is also involved * . They
are distinguished from other members of this olass in that 
they produce a speoiflo depression of the sensation of 
pain without producing unconsciousness or stupefaction: 
that is, while they do not, in non-toxic doses, affect the 
senses of sight, hearing, smell or even touch, they do 
markedly raise the threshold at which a stimulus produces 
a painful sensation* Other classes of drugs, the anti­
pyretics (such as aspirin), and the euphorlgenics (the 
tetrahydrocannabinols), also possess some analgesic 
activity, but the effect is very mueh weaker than that of 
the opiates and they are not classed as true analgesics*
Throughout the entire history of analgesia morphine 
has played a dominant role, and indeed, until the last 
decade, it has with a few of its derivatives been the only 
known drug possessing true analgesic activity* From very 
early times, at first as the crude extract, opium, and later 
as the pure alkaloid, morphine has been widely recognised 
for its analgesic properties; and today, still probably 
the most common and most effective analgesic, it has become 
also the model and standard for the synthetic analgesics of 
the future* Morphine was isolated from opium, the mixture 
of alkaloids present in the natural extract of poppy seeds, 
by Sertuemer in 1825, and was recognised as being the main 
analgesic constituent of the mixture, of which it forms
approximately 10 per cent. The structure now accepted
was proposed by Gulland and Robinson in 1925, although 
owing to the difficulty of synthesising appropriate deri­
vatives conclusive proof of the structure could not then
4be given* Recent synthetic work of R. Grewe and co- 
workers, however, has now furnished almost incontro­
vertible evidence of the correctness of this structure. 
Various two-dimensional representations of the complex 
three-dimensional structure are possible: the representa­
tion (la) given by Gulland and Robinson emphasises the 
phenanthrene portion of the molecule, while the variation 
(lb) later adopted by 0. Schaumann5 and others emphasises 
the 4-phenylpiperidine portion.
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While morphine is even today one of the most 
indispensable and important drugs used in therapeutics, its 
beneficial effect in relieving pain is greatly marred by 
numerous medically-undesirable side reactions. Morphine
depresses the respiratory centre, an effect which is 
responsible for its toxic properties, produces nausea and 
has a variety of other effects on the central nervous 
system. Tolerance probably greater than that which can 
be acquired for any other drug is very rapidly established. 
And most serious of all, morphine and its derivatives are 
the most addictive drugs known, the regular use of morphine 
for only a few weeks producing addiction which is pathologi­
cal as well as psychological, and dangerous collapse may 
result on withdrawal of the drug. On social as well as 
medical grounds it therefore became desirable to obtain a 
substitute for morphine, which would be free from the 
tendency to produce tolerance and addiction, and which would 
retain the full analgesic effect with a minimum of side- 
effects. The lack of knowledge of the manner in which 
drugs exert their pharmacological effects, and the extreme 
complexity of the system of control of the functions of the 
body, made it inevitable that the problem be approached in 
a largely empirical manner.
Intensive work began in 1929, and the first phase 
involved mainly chemical operation on the morphine molecule, 
though a number of purely synthetic compounds mostly based 
on the concept of morphine as a phenanthrene or dibenzfuran
5.
derivative were also prepared. A number of active deriva­
tives of morphine were obtained by relatively minor modifica­
tion of the various functional groups (the alcoholic and 
phenolic hydroxyl groups, the ether-oxygen bridge and the 
tertiary nitrogen atom), and some of these have received 
considerable recognition as therapeutics, but in no case 
was the addictive tendency eliminated. The most active 
of the purely synthetic compounds had a potency approximately 
Viotk that of morphine*
The second phase began in 1938 with the discovery by
fiEisleb and Schaumann that ethyl-4-phenyl-l-methylpiperidine- 
4-carboxylate (pethedine, dolantin, demerol; II), origin­
ally designed as an antispasmodic, possessed also definite 
analgesic properties. Closer consideration of this com­
pound revealed that its 4-phenylpiperidine skeleton con­
stituted a portion of the morphine molecule. This chance 
discovery gave a great impetus to the synthesis of simple 
compounds based on fragments of the morphine structure and
has led to the preparation of a
e-coa
number of compounds of considerable 
analgesic activity. Most of these 
compounds have not as yet received 
sufficient clinical evaluation tox /
N
\n* permit an estimate to be made of
II.
their addictive tendencies, but it has been shown that in 
pethidine the danger of addiction, while not eliminated, 
has been considerably reduced.
This work has been comprehensively reviewed, the 
first section dealing mainly with morphine and its deriva­
tives by L.F. Small and o t h e r s ^ a n d  the second, 
dealing with synthetic compounds} by Bergel and Morrison 
and other workers^* . It is therefore proposed to
mention here only the more important information on 
analgesics gained from this work, and to outline as briefly 
as possible the extent of the synthetic work. Those 
portions of the work directly related to the experimental 
part of this thesis will be treated in more detail in the 
appropriate sections.
The effects of modification of the functional groups 
of morphine on the analgesic activity may be summarised as 
follows
Phenolic hydroxyl group. Blocking, by etherification, 
reduces analgesic activity.
Alcoholic hydroxyl group. Etherification, acetylation or
replacement by halogen increases both activity 
and toxicity. Oxidation to a keto-group or 
replacement by hydrogen, usually accompanied 
by saturation of the double bond 7:8, has a
similar effect. All these changes tend to 
decrease the duration of action.
Ether-oxygen bridge. Rupture of this decreases activity 
and toxicity.
Tertiary nitrogen atom. This appears to he the most criti 
cal point of the molecule. Replacement of the 
methyl group with other alkyl or alkenyl groups 
generally decreases the activity. Transforma­
tion of the tertiary nitrogen atom to secondary 
or quaternary almost completely destroys the 
analgesic activity, as does rupture of the 
piperidine ring.
Substitution. In the aromatic ring this decreases activity 
in the alicyclic ring the effect varies depend­
ing on other features of the molecule.
In the field of synthetic analgesics, the attached
table (pp.7& - 7d), which is taken from the review of
11Bergel and Morrison , provides a summary of the main types 
of compounds which have been prepared, and the fragment of 
the morphine molecule on which each Is modelled. In most 
cases a number of closely related compounds corresponding 
to each main type was prepared. It will be noted that not 
all the compounds depicted possessed marked analgesic 
activity.
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Prom the work on morphine and related compounds it 
Is seen that while modification of the various functional 
groups results in modification of the activity, it is not 
possible to relate analgesic activity directly to any 
particular group* The tertiary nitrogen atom, however, 
appears to be essential, and this is confirmed by the later 
synthetic work, for It is a feature of every well-established 
potent analgesic. (In synthetic compounds, however, as 
distinct from morphine derivatives, it need not form part
14of a piperidine ring.) 3 :3-Diphenyl-1-ethy1-2-pyrrolidone
has been claimed as a sole exception to this rule, but It 
remains to be seen whether the potency of this compound 
justifies its classification as a true analgesic, or whether 
It should be classed with the antipyretics and euphorigenics 
whose potency Is of a low order and which are mainly non- 
basic in character.
Similarly, it has not been possible to relate
addiction to any particular functional group, and no active
derivative of morphine is known which does not produce
addiction. However, some advance in this direction has
15been made with the discovery of methyldihydromorphinone 
(metopon; III), which combines considerably enhanced 
analgesic potency with a much reduced tendency to tolerance 
and addiction. Of the synthetic compounds probably only
pethldin® (II) and amidone (IV) have received sufficient
/
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clinical evaluation to permit an assessment to be made, 
and here again the tendency to addiction is present on a 
reduced scale* Other new drugs, among them /3 -pethidine
(V), have shown promise in this direction in preliminary
16trials , and give reason to hope that the problem of
addiction may soon be overcome.
An encouraging step In the elimination of other un-
17desirable effects has been made by Unna and Hart and 
18McCawley who found that replacement of the N-methyl group 
of morphine by am N-allyl group eliminated the respiratory 
depressant effect of the compound, apparently without 
markedly impairing the analgesic potency. The side-effects 
of the various synthetic compounds are not yet well established 
Thus by largely empirical methods a fair measure of 
success has been achieved in the preparation of new compounds 
in which the analgesic effect is largely dissociated from 
the undesirable side-effects which accompany it in morphine.
Nevertheless the drugs so far obtained are far from ideal, 
and a rational basis for future work is greatly to be 
desired. Progress in this direction has been slow.
The search for a simple pharmacodynamic group 
responsible for the analgesic effect has not yielded any 
definite result. The functional groups of morphine, with 
the exception of the tertiary nitrogen atom, appear not to 
be of critical importance in themselves as they can be 
modified considerably without destruction of the activity 
of the compound, although these modifications do cause 
changes of potency. A similar state of affairs seems to 
exist among the synthetic compounds such as pethidine and 
the 4-phenyl-4-hydroxy-l-alkylpiperidine esters. McDonald 
and others^, in considering pethidine, came to the con­
clusion that the general shape or fit of the whole molecule 
as compared with morphine is more important than the 
precise duplication of any one fragment, and the importance 
of steric arrangement Is evident throughout the entire field. 
The resemblance between pethidine (II) and morphine (i) is 
marked, and replacement of the carbethoxy group by the
isomeric propionoxy group (VI), a change which Lee and 
19co-workers state increases the steric resemblance to 
morphine, also increases the activity. (The two-dimension­
al structures shown here do not give an exact steric
representation of the actual three-dimensional molecules)*
20Lee further speculated that one of the two possible 
stereoisomers of 1 :3-dime thy 1-4-phenyl-4-propionoxy- 
piperidine should bear a particularly close steric resemblance 
to morphine and should hence be more active than the other; 
and it was found that the trans isomer was indeed more
active than the other* Similarly, it has been shown that
21 22 N-methylmorphinan and 3-hydroxy-N-methylmorphinan (VII),
whose steric resemblance to morphine is extremely close,
possess activity of the same order as that of morphine*
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And even compounds such as amidone (IV), which at first 
sight appear to differ considerably from morphine, are 
believed to have a very close steric similarity*
A correlation of the effect of functional groups
and the importance of steric arrangement has been made in
23 24-the hypothesis of C.C. Pfeiffer 9 , which relates certain
types of pharmacological activity with the nature and 
spatial arrangement of prosthetic (functional) groups in 
the drug molecule, and postulates that analgesics exert 
their pharmacological effect by specifically blocking 
certain metabolites essential for the central nervous 
system. Suggesting that greater correlation and under­
standing of structure-activity relationships might be ob­
tained by depicting structural formulae in three dimensions, 
with bond distances accurately calculated, a procedure 
successfully employed by Schueler^ in relating estrogenic 
activity to chemical constitution, and assuming a cellular 
surface action as a possible mode of action of the drugs 
considered, he has shown the presence of certain prosthetic 
groups at comparatively critical interatomic distances to be 
a feature of all drugs possessing marked muscarinic (para­
sympathomimetic stimulant) action, e.g., acetylcholine, 
pilocarpine, etc. Similarly, all potent inhibitors of 
acetylcholine stimulation possess these same groups at the 
same distance apart, but placed now in the centre of a large 
umbrella-like molecule. The simplest concept is that these 
blocking molecules adhere to the receptors on the cell 
surface by means of the prosthetic groups they contain, and
by their continued adherence and difficult degradation pre­
vent the smaller stimulant molecules reaching the acceptors 
on the cell. Lack of one or more of the prosthetic groups 
reduces, but does not entirely destroy, the activity of a 
compound. Since blocking molecules have a characteristic 
chemical configuration, Pfeiffer suggests that the hypothesis 
may be extended to certain other pharmacological series, 
including the analgesics. He emphasises, however, that 
while the prosthetic groups and their arrangement may be 
mainly responsible for the pharmacological action of a drug, 
this is also strongly influenced by the surrounding molecular 
structure and the ease of degradation of this in the body: 
and hence, while it may become possible to predict pharmaeologi 
cal activity from a study of prosthetic groupings, the use­
fulness of a drug will depend on the associated molecular 
structure and will still require to be determined by experiment
This hypothesis has still to be confirmed. Bio­
chemical information in particular is notably lacking, but 
the collection and correlation of necessary physicochemical 
data should be facilitated by the availability of the 
relatively simple synthetic compounds in place of the undoubted 
ly complex compounds related to morphine.
Thus progress on the theoretical side, while slight 
as yet, holds promise for the future. On the practical
side considerable success has already been achieved in the 
production of drugs in which addictive tendency and other 
side-effects have largely been dissociated from the desired 
analgesic activity: but here, too, the goal, a potent and
completely safe analgesic, still lies ahead.
ANTISPASMODICS.
Spasm is the violent, involuntary contraction of 
smooth (plain, involuntary) muscle, which controls mainly 
the hollow organs of the body, and is activated by the 
autonomic nervous system. On account of the disturbing 
effect of spasm on the proper functioning of the organs 
controlled by smooth muscle, and hence of the body as a 
whole (for example in asthma, in which spasm of the bronchial 
muscles results in arrest of respiration), and because of 
the pain which usually accompanies it, it is most desirable 
to have means of relaxing spastic muscle.
The autonomic nervous system consists of two sets 
of nerves, the sympathetic and the parasympathetic; and 
most smooth muscles have this double nerve supply, the two 
sets acting in opposition, as augmentor and inhibitor, to 
regulate the activity of the muscle. Spasm is commonly 
related to over-activity of the parasympathetic nervous 
system; hence stimulation of the complimentary sympathetic 
nervous system, or, more accurately, simulation of its
15.
effects, by drugs such as adrenaline will to some extent 
relieve the condition: these sympathomimetic drugs are
not, however, classed as true antispasmodics.
Two types of spasm are to be distinguished. The 
first, neurotropic (neurogenic) spasm is caused by nervous 
stimulation of the muscle, and can be simulated by com­
pounds such as acetylcholine, which is believed to be 
instrumental in conveying the impulse from the nerve to the 
muscle. The second, musculotropic (myogenic) spasm is 
caused by direct stimulation of the muscle by compounds 
such as histamine and barium chloride. In practice it is 
not always convenient to distinguish which type of spasm 
Is involved, hence it is desirable that an antispasmodic 
should be active against both types.
Synthetic antispasmodics are based largely on two 
naturally-occurring drugs, papaverine (VIII) and atropine (IX).
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These, however, in addition to the over-abundance of side- 
effects so common among natural drugs, have the added dis­
advantage of not being equally effective against both types 
of spasm. While papaverine is rather more active against 
musculotropic than neurotropic spasm, and much more active
than atropine against musculotropic spasm, atropine Is by
26far the more effective against neurotropic spasm . The 
aim of synthetic work Is a compound combining the papaverine 
activity against musculotropic spasm with the atropine 
activity against neurotropic spasm, and free from the side- 
effects of these drugs.
Atropine (IX) is the tropic acid (phenyl«hydroxy- 
methylacetic acid) ester of the basic alcohol tropine, and 
in the search for synthetic antispasmodics It was natural 
that the effect of substituting other basic alkyl groups 
in place of the tropine portion of the atropine molecule, 
or other acids in place of tropic acid, or both, should be 
extensively investigated. A very large number of esters, 
based on the concept of atropine as the ester of a basic 
alcohol and a disubstituted acetic acid, has been prepared, 
and several useful antispasmodics have thus been obtained.
Of these may be mentioned syntropan (the f  ft -dimethyl-y - 
diethylaminopropy1 ester of a* -tropic acid; X), trasentin 
( p  -diethylaminoethyldiphenylacetate; XI) and its hexahydro 
derivative trasentin-6H ( p  -diethylaminoethylphenylcyclo-
hexylacetate; XII): these are used In the form of salts,
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usually the hydrochloride. The last, trasentin-6H, is
07
reported to have a neurogenic activity comparable to 
that of atropine, and a musculotropic activity equal to 
that of papaverine: it is more toxic than atropine, but Is
relatively free from side effects# Similar esters of
28xenylacetic acid (in which two phenyl groups are attached
to each other as in diphenyl), a c -naphthy lace tic acid**®
30and fluorene-9-carboxylic acid have also been found to 
possess high activity, the p  -diethylaminoethyl ester of 
the last mentioned being the well-known antispasmodic pava- 
trine. A number of amides corresponding to these esters 
has been prepared, but in general these are rather less 
active.
Halpemu , from his work on esters of phenylalkyl- 
acetic acids, has suggested that the basic alcohol portion 
of the molecule determines the type of activity (neurotropic 
or musculotropic) of the compound, esters derived from basic
ethanols or propanols being mainly neurotropic, and those 
from basic pentanols mainly musculotropic antispasmodics; 
and that the acid portion determines the intensity of the 
activity. It has not been proved, however, that this 
relationship holds equally in other sections of the field.
A considerable amount of work has also been done on 
the papaverine model. Papaverine (VIII) was isolated from 
opium in 1848, but it was not until 1913 that its anti- 
spasmodic properties were discovered. Then the rapidly 
increasing demand, and the fact that the supply (obtained 
as a by-product in the extraction of morphine from opium) 
was limited by international agreement controlling the 
production of opium, led to a search for synthetic substitutes
>tvo -
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The first aim of this work was the preparation of compounds 
as close in structure to the natural prototype as possible, 
and it is probable that these compounds, such as eupaverin 
(XIII) and perparin (which differs from papaverine only in
that the methoxyl groups have been replaced by ethoxyl), 
on account of this very close resemblance, retain most of 
the disadvantages of papaverine, such as the low solubility 
of its salts and their tendency to hydrolysis.
In an effort to overcome the disadvantages associated
extensive examination of less closely related compounds.
On the model of l:2:3:4-tetrahydropapaverine (XIV), which
possesses weak antispasmodic properties, they prepared di-p
phenylethylamine (XV), whose structural resemblance is
obvious from comparison of the formulae. This compound too
exhibited antispasmodic activity, and led to the preparation
of an extensive range of similar amines, some of which were
more active than papaverine. One of the most successful
33compounds of this type is ethyldi- ^  -phenylpropylamine 
sestron; XVI), which has a potency more than twice that of 
papaverine, and more satisfactory physical properties. 
Simpler, saturated and unsaturated, aliphatic amines, such
with papaverine, Kulz'32 and his associates carried out an
as ethyldiheptylamin©04 and 2-aminohexene-5 have also 
been shown to possess antispasmodic activity.
Reviews of the work on both atropine-type and
34papaverine-type compounds have been made by Blicke ,
• z c  37
Raymond0 and Pfeiffer and Loew . It is seen that, on 
the theoretical side, little progress has been made in the 
correlation of chemical constitution and pharmacological 
activity; for attempts to relate activity to any parti­
cular group, or to any one physical property, have been 
largely unsuccessful, though the hypothesis of Pfeiffer, 
mentioned previously in the discussion on analgesics, 
which relates activity to the presence of certain functional 
groups at specific distances apart^may be a step in this 
direction. On the practical side, however, musculotropic 
antispasmodics more active and more clinically useful than 
papaverine have been prepared; neurotropic antispasmodics 
equivalent to atropine and relatively free from its side- 
effects have been obtained; and while none of the synthetic 
compounds based on papaverine has exhibited marked neuro­
tropic activity, several esters related to atropine have 
exhibited the desired combination of musculotropic and neuro 
tropic activity in high degree. The search for synthetic 
antispasmodics, therefore, has achieved considerable success
Section !•
The Bisdiallgylamlnoalkylnaphthaleiies*
The Bisdialkylaminoalkylnaphthalenes.
The majority of potent synthetic antispasmodics 
belong to one of two classes, the amines related to papaver­
ine or the basic esters related to atropine. Of the first 
class, the range of amines which exhibit antispasmodic 
activity is very wide. Many compounds of the general type 
Ar .CHg.CH(R) *NH. CH(Rf) .CHg.Ar, where Ar = phenyl or sub­
stituted phenyl, and R and R* = hydrogen, alkyl, phenyl or
32
benzyl, show marked activity ; and the presence of an
N-alkyl group is of practical advantage as the salts of
these tertiary amines are more water-soluble and hence more
useful clinically* Compounds containing a longer carbon
chain, of the type Ar(CHg)3*NR* (CHgJ^.Ar, though less
closely related structurally to papaverine, are equally 
33Active , and compounds containing an alicyclic ring in
place of the aromatic still retain considerable potency.
35Even purely aliphatic amines such as 2-aminohexene-5 
(XVII) and ethyldiheptylamine3^ (XVIII) show some activity. 
The aminoalkyl grouping is also a feature of the synthetic
CH ■ C • Ntf* N (a) ' ^ 3
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esters related to atropine, occurring for example in 
trasentin ( f  -diethylaminoethyl-diphenylacetate), syntropan 
( p p  -dimethyl-^ -diethylaminopropyl ester of -tropic
22.
acid) and pavatrine (p -diethylaminoethyl fluorene-9- 
carboxylate). The same grouping also appears in other 
miscellaneous active compounds not directly related to
either papaverine or atropine, as for example in quinoline
38derivatives containing aminoalkyl side chains, benzo-
39fur an one derivatives such as 3 - j b -diethylaminoethyl-3- 
phenyl-2-benzofuranon© (amethone), and the -amino- 
acetamides40.
As a basic group of this type is therefore a con­
sistent feature of several classes of compounds possessing 
antispasmodic activity, it was decided to carry out a pre­
liminary investigation of compounds containing two such 
basic groups in the molecule in place of the one present in 
previous compounds, and to this end was planned the syn­
thesis of the following bisdialkylaminomethylnaphthalenes.
As these bear also some slight resemblance to analgesics of 
the diphenylpropylamine and bisphenylethylamine types dis­
cussed in the previous section, it was considered possible 
that they might possess some analgesic as well as anti­
spasmodic activity.
The compounds prepared and submitted for pharma­
cological testing, in order that a preliminary estimate of 
the antispasmodic and analgesic properties of this type of 
structure might be obtained, were 1 :4-bisisothiocarbamidomethy 1-
naphthalene (XIX), 1 :4-bisdiethylaminomethylnaphthalene (XX), 
and 1 :4-bis-N-piperidylmethylnaphthalene (XXI).
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l:4-Bischloromethylnaphthalene^ (XXII) was pre­
pared by the chloromethylation of naphthalene with boiling 
aqueous formaldehyde and hydrochloric acid. The product 
contains a quantity of the higher-melting l:5-isomer 
(m.p. 172°) which is difficult to separate from the 1:4- 
isomer (m.p. 150°)• For the first experiments pure 1:4- 
bischloromethylnaphthalene, obtained by fractional crystal­
lisation of the crude material from ethanol, was used; 
but it was found that a cruder material (m.p. ca. 132°),
obtained after only one or two crystallisations, was 
equally satisfactory and this was used in the subsequent 
condens at ions •
When l:4-bischloromethylnaphthalene was refluxed 
with thiourea in a mixture of benzene and ethanol con­
densation occurred to give 1 :4-bisisothiocarbamidomethyl- 
naphthalene hydrochlor ide (hydrochloride of XIX) which 
separated from the reaction mixture, and was also character­
ised as the pier ate.
Condensation occurred similarly between l:4-bis- 
chloromethylnaphthalene and diethylamine on refluxing in 
benzene solution, to give 1 :4-bisdiethylaminomethylnaphthal- 
ene (XX), which was characterised as the hydr ochl or ide and 
the picrate» Diethylamine, however, differs from thiourea 
in being a sufficiently strong base to compete with the 
condensation product for the hydrogen chloride liberated in 
the reaction, and thus tends to be removed from the reaction 
as insoluble hydrochloride before the condensation can pro­
ceed to completion. To obtain complete reaction, therefore, 
two molecular proportions of diethylamine were used. The 
mixed bases were then extracted and the excess diethylamine 
removed by evaporation to leave the desired condensation 
product# By this general method bisdialkylaminomethy1- 
naphthalenes of this type are most conveniently obtained.
1 :4-Bis-N-plperidylmethylnaphthalene (XXI) was
similarly prepared by the condensation of l:4-bischloro 
methylnaphthalene and piperidine, and was characterised 
also as the hydrochloride.
condense 1 :4-bischloromethylnaphthalene with tetramethyl­
thiourea. This might be expected to occur with difficulty
if at all, involving as it does considerable rearrangement 
within the thiourea molecule. However, when bischloro- 
methylnaphthalene and tetramethylthiourea were refluxed in 
xylene solution for approximately twenty hours reaction did 
occur, and a quantity of insoluble, deliquescent salt 
separated from the reaction mixture. This decomposed on 
distillation to give tetramethylthiourea, and was hence pre 
sumed to be the methochloride of tetramethylthiourea. It 
was therefore apparent that some condensation had actually 
occurred. The reaction, however, was slow and incomplete, 
and it was not possible to isolate any of the desired con­
densation product from the non-volatile tetramethylthiourea 
also present In the mixed basic product of the reaction.
In connection with this work attempts were made to
M>n«.
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Specimens of 1 :4-bl8lsothiocarbamidometh;yl-
naphthalene hydrochloride, 1 :4-bisdiethylaminomethylnaph-
thalene hydrochloride and 1:4-bis-N-piperidylmethy1-
naphthalene hydrochloride were submitted for pharmacological
testing, and the results of the tests on the first two of
42these have been published . Both of these compounds 
showed some antispasmodic activity, which was approximately 
V^th that of pavatrine against barium-induced spasm but 
only very slight against spasm induced by histamine or 
acetylcholine. As antispasmodics, therefore, these com­
pounds are not particularly successful. Both compounds, 
however, displayed an unexpected activity as analgesics.
Both were approximately equal to pethidine in potency 
when tested on mice, and while 1 :4-blsisothlocarbamldo- 
methylnaphthalene hydrochloride (hydrochloride of XIX) 
was approximately twice as toxic as pethidine, l:4-bis- 
diethylaminomethylnaphthalene hydrochloride (hydrochloride 
of XX) had less than half the toxicity of pethidine.
Unlike pethidine, which produces motor excitement, both 
these compounds were depressant. Bisdiethylaminomethyl- 
naphthalene hydrochloride, the more promising compound on 
account of its low toxicity, was then submitted for clinical 
trial, but the preliminary report of this was less satis­
factory and indicates that the compound is in practice a 
less efficient analgesic than pethidine. Extracts from
this report are given below
”The analgesic qualities of this drug have been 
tried in a number of selected cases of pain due to nervous 
system disease (syringomyelia, brachial plexus, pressure 
lesion and tabes dorsalis), and in a few cases of pain due 
to pleural lesions. Doses of 25 - 100 mg. intravenously 
proved ineffective as analgesics, and it was found to be 
effective in doses of .5 g. and upwards. At a dose of 
•5 g. intravenously it confers relief of pain which 
corresponds in some cases to that given by 100 mg. of 
pethidine intravenously; other patients thought it less 
effective but of longer duration; analgesia wears off in 
about four hours, though some effect may remain for a 
longer period. Orally it has not been satisfactory as 
too large a bulk has been necessary; it has not been tried 
in tablet form. The flavour is unpleasant; it should be 
noted that in doses of .5 g. intravenously it is detected 
by taste after the usual time interval and gives a good 
indication of circulation time (arm-tongue). No side 
effects have as yet been apparent. It does not appear to 
be a euphoriant.”
These tests, therefore, while indicating that the 
compounds already tested are unlikely to be of direct 
practical value, nevertheless do establish the analgesic
potentialities of this bisdialkylamihomethylnaphthalene 
type of structure. And this is of interest, not only 
because this is a new type of compound to exhibit anal­
gesic activity, but also because of the relative simplicity 
of the structure. As has been mentioned before, con­
siderable efforts are now being made to correlate analgesic 
activity with chemical constitution; and tentative specu­
lations have already been made, as, for example, Pfeiffer*s 
speculations on the possible significance of the electro­
static effects of functional groups and the interatomic 
distances between them. While it is probable that much 
biochemical and physicochemical information will require to 
be obtained before any such correlation can be achieved, 
compounds of the bisdialkylaminomethylnaphthalene type, 
and possibly even simpler related compounds, should be of 
value in establishing the minimum chemical requirements for 
an analgesic, and in providing simple models for the study 
of physicochemical relationships.
Section 2*
The 4-phenyl-4-hydroxyplpe ridine e .
The 4-pheny1-4-hydroxypiperidine3 *
Pethidine (II), introduced in 1939 by Eisleb and 
6Schaumann was the first totally synthetic analgesic to 
compete seriously with morphine in clinical practice.
In addition to considerable analgesic potency It possessed 
the advantages of a considerably reduced tendency to cause 
addiction and a relatively simple structure as compared 
with the complexity of morphine, and it was natural that 
this success should inspire further work on similar 
piperidine derivatives.
One line of approach was the preparation by Jensen 
and Lundquist43 of a number of esters of 4-pheny 1-4-hydroxy- 
1-methylpiperidine of the type (XXIII; R = Me), in which
v
the ear bethoxy group of pethidine is 1 reversed1 in the fora 
of the eater group* Of the aeries (R* * Me, Et Fr) pre­
pared by these workers the propionoxy derivative (XXIII;
R* * It) was found to be the most active, having 5 - 10 
times the potency of pethidine (i.e#, approximately the same
44potency as morphine). Lee and his associates later 
carried out an intensive investigation of this group of 
compounds, and confirmed that maximum activity is obtained 
when in (XXIII) R * Me and R f = Et. Increase in the 
length of R decreases activity, while branching of it 
leads to increased stability of the ester group to hydrolysis. 
These workers also found that while the piperidols (XXIV) 
themselves showed only slight activity, the tetrahydro- 
pyridines of type (XXV) obtained from these by dehydration 
were moderately active, l-ethyl-4-p-methoxyphenyl-l:2:5:6- 
tetrahydropyridine possessing approximately V3rd the
t
potency of pethidine. The saturated piperidines obtained 
by hydrogenation of the tetrahydropyridines were of equal 
activity. Replacement of the phenyl group by an alkyl,
4.5
cycloalkyl, heterocyclyl or heterocycloalkyi* group in­
variably decreased the activity; the only compound of 
interest being 4-cyclohexyl-4-propionoxy-l-methylpiperidine, 
with a potency about V3rd that of the phenyl analogue.
This is the first potent analgesic not to contain a phenyl 
ring, and has the added advantage over its phenyl counter­
part in that it is reasonably stable in aqueous solution*
The most active compound of this piperidine type was 1:3- 
dln»thyl-4-phenyl-4-propionoxypiperidine (XXVI)* Prom 
the conception of morphine as a derivative of trans- 
octahydroisoqulnoline, an assumption as yet improved, Lee
20andZiaring calculated that on© of the two possible stereo­
isomers (the trans) should bear a particularly close steric 
resemblance to morphine, and speculated that It should 
therefore be more active than the other isomer. This 
proved to be the case, one isomer being over 5 times as 
potent as morphine, while the other approximately equalled
morphine in potency. A further development in this field
46was the preparation by Badger and others of 4-phenyl-4- 
acetoxy-1-methyl-2:2:6:6-tetramethylpiperidine (XXVII), 
for vhich analgesic activity is claimed.
It was therefore decided, in continuation of the 
above work, to explore further the effect of alkyl sub­
stituents i n  the piperidine ring of these 4-phenyl-4- 
acyloxy-l-alkylpiperidines, and to this end was planned the 
synthesis of 4-phenyl-4-hydroxypiperidine (XXVIII; R * H) 
and the corresponding N-methyl compound, from which It was 
expected a series of esters of the desired type could be
32
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obtained. As these compounds are related to the natural 
antispasmodic atropine (IX) in the same sort of way in 
which the synthetic local anaesthetics the eucaines (XXIX) 
are related to the naturally occurring cocaine (XXX), and 
in view of the proved antispasmodic activity of the related 
compounds pethidine and the 4-pheny 1-4-ace toxy-1-methyl- 
piperidines, it was expected that they might possess anti­
spasmodic as w e n  as analgesic activity.
43Jensen and Lundquist , and later Lee and his 
44,47
associates , obtained 4-aryl- |
4-acyloxypiperidines of type c -c.c { £
(XXIII) by reaction of the
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a p p r o p r i a t e  4 - p i p e r i d o n e  w i t h  a r y l m a g n e s i u m  h a l i d e ,  f o l l o w e d  
b y  e s t e r i f i c a t i o n  o f  t h e  e a r b i n o l  s o  o b t a i n e d  w i t h  t h e  
a p p r o p r i a t e  a c i d .  T h i s  m e t h o d  w a s  f o l l o w e d  i n  t h e  p r e ­
p a r a t i o n  o f  2  : 2  : 6 - t r i m e t h . y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e s  
b y  t h e  f o l l o w i n g  r o u t e : -
M e s i t y l  o x i d e  ( X X X I )  c o n d e n s e d  w i t h  a q u e o u s  a m m o n i a
4 8
i n  t h e  c o l d  t o  f o r m  4 - a m i n o - 4 - m e t h y l p e n t a n - 2 - o n e  
( d i a c e t o n a m i n e ;  X X X I I )  w h i c h  w a s  i s o l a t e d  a s  t h e  h y d r o g e n  
o x a l a t e .  T h i s  o x a l a t e  c o n d e n s e d  w i t h  a c e t a l  o n  r e f l u x i n g
C* ch -e
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i n  e t h a n o l  s o l u t i o n  t o  g i v e  t h e  h y d r o g e n  o x a l a t e  o f  2 : 2 : 6 -
4 9
t r i m e t h y l - 4 - p i p e r i d o n e  ( v i n y l d i a c e t o n a m i n e ; X X X I I I ) ,
f r o m  w h i c h  t h e  p i p e r i d o n e  i t s e l f  w a s  i s o l a t e d .  2 : 2 : 6 -  
T r i m e t h y 1 - 4 - p i p e r I d o n e  r e a c t e d  w i t h  p h e n y l m a g n e s i u m  b r o m i d e ,
a n d  o n  d e c o m p o s i t i o n  o f  t h e  G r i g n a r d  c o m p l e x  w i t h  a q u e o u s
5 0
a m m o n i u m  c h l o r i d e  g a v e  2  : 2 : 6 - t r i m e t h y l - 4 - p h e n y 1 - 4 -  
h y d r o x y p i p e r i d i n e  ( X X X I V ) ,  i s o l a t e d  a s  t h e  h y d r o c h l o r i d e ,  
f r o m  w h i c h  t h e  f r e e  b a s e  w a s  o b t a i n e d  a n d  c h a i r a c t e r i s e d  a s  
t h e  h y d r o c h l o r i d e , h y d r o g e n  o x a l a t e , p i c r a t e  a n d  a c e t a t e .
T h e  p r o d u c t  i s o l a t e d  d i r e c t l y  f r o m  t h e  r e a c t i o n  
w a s  p r o v e d  b y  m i x e d  m e l t i n g  p o i n t  d e t e r m i n a t i o n  a n d  b y  
e x t r a c t i o n  o f  t h e  b a s e  t o  b e  e s s e n t i a l l y  t h e  h y d r o c h l o r i d e  
o f  2 : 2 : 6 - t r l m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e . T h e  
a n a l y s i s ,  h o w e v e r ,  w a s  n e i t h e r  s a t i s f a c t o r y  n o r  c o n s i s t e n t ,  
a n d  t h e  m e l t i n g  p o i n t  ( 2 5 0  -  2 5 1 ° )  d i f f e r e d  s l i g h t l y  f r o m  
t h a t  ( 2 4 7  *  2 4 8 ° )  o f  a n  a u t h e n t i c  s p e c i m e n  o f  t h e  h y d r o ­
c h l o r i d e  p r e p a r e d  f r o m  t h e  p u r i f i e d  b a s e .  T h i s  m a y  b e  a  
s o l v a t e d  f o r m  o f  t h e  h y d r o c h l o r i d e ,  a n d  p r o b a b l y  c o n t a i n s  
o t h e r  i m p u r i t i e s  w h i c h  a r e  n o t  r e a d i l y  s e p a r a t e d  b y  c r y s t a l ­
l i s a t i o n .  A n  i n c r e a s e  i n  t h e  t i m e  o f  r e f l u x i n g  o f  t h e  
r e a c t i o n  m i x t u r e  s l i g h t l y  i n c r e a s e d  t h e  y i e l d  o f  t h i s  
m a t e r i a l ,  b u t  t h e  b a s e  i s o l a t e d  w a s  l e s s  p u r e .
2 : 2 : 6 - T r i m e t h y 1 - 4 - p h e n y 1 - 4 - h y d r o x y p i p e r i d i n e  i s  
d i m o r p h i c .  T h e  s t a b l e  f o r m  c r y s t a l l i s e s  i n  c o l o u r l e s s  
n e e d l e s  ( f r o m  l i g h t  p e t r o l e u m )  m . p *  9 1  -  9 2 ° .  W h e n  t h i s  
f o r m  i s  d i s t i l l e d ,  o r  h e a t e d  i n  a l c o h o l  s o l u t i o n  f o r  s e v e r a l  
h o u r s ,  a  s e c o n d  f o r m ,  c o l o u r l e s s  p r i s m s  ( f r o m  l i g h t  p e t r o l e u m )  
m * p .  9 6  -  9 7 °  i s  o b t a i n e d :  o n  r e p e a t e d  c r y s t a l l i s a t i o n  t h i s
r e v e r t s  t o  t h e  o r i g i n a l  f o r m .
1 : 2 : 2 : 6 - T e t r a m e t h y l - 4 - p i p e r i d o n e  i s  n o t  r e a d i l y
a v a i l a b l e ,  a s  p i p e r i d o n e s  o f  t h e  t y p e  ( X X X I I I )  a r e  r e  -
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s i s t a n t  t o  d i r e c t  N - - m e t h y l a t i o n  . T h e  c o r r e s p o n d i n g  
a l c o h o l s ,  h o w e v e r ,  a r e  r e a d i l y  m e t h y l a t e d ,  a n d  o n  w a r m i n g  
w i t h  a q u e o u s  f o r m a l d e h y d e  2  : 2 : 6 - t r i m e t h y 1 - 4 - p h e n y 1 - 4 -  
h y d r o x y  p i p e  r i d i n e  w a s  r e a d i l y  c o n v e r t e d  t o  1 : 2 : 2 : 6 -  
t e t r a m e  t h y  1  - 4  - p h e n y  1  - 4  - h y d r o x y p  1  p e  r i d i n e  ( X X X V ) ,  w h i c h  w a s  
c h a r a c t e r i s e d  a s  t h e  h y d r o c h l o r i d e  a n d  p i c r a t e .
B o t h  t h e s e  t e r t i a r y  a l c o h o l s  ( X X X I V  a n d  X X X V )  
r e a d i l y  u n d e r g o  d e h y d r a t i o n ,  e s p e c i a l l y  i n  a c i d  m e d i a ,  t h o u g h  
s l i g h t  d e h y d r a t i o n  o c c u r s  a l s o  d u r i n g  d i s t i l l a t i o n  i n  
v a c u u m *  O n  w a r m i n g  w i t h  a l c o h o l i c  h y d r o g e n  c h l o r i d e  
2 : 2 : 6 - t r i m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  g a v e  2 : 2  : 6 ~  
t r l m e t h y 1 - 4 - p h e n y 1 - 1 : 2  : 5 : 6 -  ( o r  1 : 2 : 5 : 6 ) - t e t r a h y d r o p y r i d l n e  
( X X X V I  o r  X X X V I I ;  R  =  H ) ,  a  c o l o u r l e s s  o i l ,  d a r k e n i n g  
P h  Ph
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r a p i d l y  o n  e x p o s u r e  t o  a i r ,  w h i c h  w a s  c h a r a c t e r i s e d  a s  t h e  
h y d r o c h l o r i d e  a n d  h y d r o g e n  o x a l a t e * E v e n  t h e  m i l d  a c i d
conditions used in the preparation of salts may bring about
p a r t i a l  d e h y d r a t i o n ,  a n d  i n  t h e  p r e p a r a t i o n  o f  t h e  h y d r o ­
c h l o r i d e  o f  2 : 2 : 6 - t r i m e t h y l - 4 - p h e n y 1 - h y d r o x y p i p e r i d i n e  b y  
t h e  a d d i t i o n  o f  h y d r o g e n  c h l o r i d e  t o  a n  e t h e r  s o l u t i o n  o f  
t h e  b a s i c  a l c o h o l ,  a  q u a n t i t y  o f  t h e  h y d r o c h l o r i d e  o f  t h e  
d e h y d r a t e d  p r o d u c t  w a s  a l s o  i s o l a t e d .  1 : 2 : 2  : 6 - T e t r a m e t h y l -  
4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  w a s  s i m i l a r l y  d e h y d r a t e d  w i t h  
e q u a l  f a c i l i t y  t o  g i v e  1 ; 2 : 2  : 6 - t e t r a m e t h y 1 - 4 - p h e n y l - 1 : 2 ; 5  ; 6 -  
( o r  1 : 2 : 5  : 6 ) - t e t r a h y d r o p y r i d l n e  ( X X X V I  o r  X X X V I I ;  R  =  M e ) ,  
a l s o  a  c o l o u r l e s s  o i l  w h i c h  d a r k e n e d  r a p i d l y  o n  e x p o s u r e  t o  
a i r ,  a n d  w h i c h  v / a s  c h a r a c t e r i s e d  a s  t h e  p i c r a t e . A t t e m p t s  
t o  o b t a i n  u r e t h a n e  d e r i v a t i v e s  o f  t h e s e  a l c o h o l s  b y  r e ­
a c t i o n  w i t h  p h e n y l i s o c y a n a t e  a l s o  r e s u l t e d  i n  d e h y d r a t i o n  o f  
t h e  a l c o h o l ,  t h e  w a t e r  e l i m i n a t e d  r e a c t i n g  w i t h  t h e  p h e n y l -  
i s o c y a n a t e  t o  f o r m  c a r b a n i l i d e  •
A t t e m p t s  t o  o b t a i n  e t h e r s  o f  2  : 2  : 6 - t r i m e t h y l - 4 - p h e n y l -  
4 - h y d r o x y p i p e r i d i n e  o f  t h e  t y p e  ( X X X V I I I )  ^
e f f e c t ,  a n d  w a r m i n g  m e r e l y  b r o u g h t  a b o u t  d e h y d r a t i o n .  
T r e a t m e n t  o f  t h e  G - r i g n a r d  c o m p l e x  f o r m e d  f r o m  2 : 2 : 6 - t r i -  
m e t h y l - 4 - p i p e r i d o n e  a n d  p h e n y I m a g n e s i u m  b r o m i d e  w i t h  
d i m e t h y l  s u l p h a t e  w a s  i n e f f e c t i v e  u n d e r  m i l d  c o n d i t i o n s ,
w e r e  u n s u c c e s s f u l .  T r e a t m e n t  o f  t h e
h y d r o x y p i p e r i d i n e  w i t h  t h e  a p p r o p r i a t e  a l -  n v  ^  ^
N'
c o h o l  i n  t h e  c o l d  i n  t h e  p r e s e n c e  o f
C50
s u l p h u r i c  a c i d  c a t a l y s t  w a s  w i t h o u t
M
a n d  y i e l d e d  o n l y  t h e  h y d r o x y p i p e r i d i n e ;  u n d e r  m o r e  v i g o r o u s  
c o n d i t i o n s  a  " b a s i c  o i l  w a s  o b t a i n e d  w h i c h ,  h o w e v e r ,  d e c o m p o s e d  
w h e n  p u r i f i c a t i o n  b y  f r a c t i o n a l  d i s t i l l a t i o n  i n  v a c u u m  w a s  
a t t e m p t e d .
A t t e m p t s  t o  e s t e r i f y  2 : 2 % 6 - t r i m e t h y l -  a n d  1 : 2 : 2 : 6 -  
t e t r a m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  w e r e  l a r g e l y  u n ­
s u c c e s s f u l  . W h e n  2 : 2 : 6 - t r i m e t h y l - 4 - p h e n y l - 4 - h y d r o x y -  
p i p e r i d i n e  ( X X X I V )  w a s  t r e a t e d  w i t h  a c e t i c  a n h y d r i d e  t h e
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a m i n o  g r o u p  p r o v e d  m u c h  m o r e  r e a c t i v e  t h a n  t h e  h y d r o x y l ,  a n d  
t h e  o n l y  p r o d u c t  i s o l a t e d  w a s  1 - a c e t y l - 2  : 2  : 6 - t r i m e t h y l - 4 -  
p h e n y l - 4 - h y d r o x y p i p e r i d i n e  ( X X X I X )  • T r e a t m e n t  o f  t h e  
G r i g n a r d  c o m p l e x  f o r m e d  f r o m  2 : 2 : 6 - t r i m e t h y 1 - 4 - p i p e r i d o n e  
a n d  p h e n y l m a g n e s i u m  b r o m i d e  w i t h  a c e t i c  a n h y d r i d e ,  h o w e v e r ,  
d i d  g i v e  a  v e r y  s m a l l  q u a n t i t y  o f  2  : 2 ; 6 - t r i m e t h y l - 4 - p h e n y  1 -  
4 - a c e t o x y p i p e r i d i n e  a c e t a t e  ( a c e t a t e  o f  X L ) ,  w h i c h  w a s  a l s o
c h a r a c t e r i s e d  a s  t h e  h y d r o c h l o r i d e  : t h e  m a i n  b u l k  o f  t h e
p r o d u c t  w a s  t h e  t e t r a h y d r o p y r i d i n e  ( X X X V I  o r  X X X V I I ;
R  =  H )  • T h e  a c e t o x y p i p e r i d i n e  a c e t a t e  i s  e v i d e n t l y  f o r m e d  
d u r i n g  t h e  d i s t i l l a t i o n  o f  t h e  m i x e d  p r o d u c t  o f  t h e  r e a c t i o n  
b y  p a r t i a l  d e c o m p o s i t i o n  o f  t h e  a c e t o x y p i p e r i d i n e  w i t h  
l i b e r a t i o n  o f  a c e t i c  a c i d ,  w h i c h  t h e n  c o m b i n e s  w i t h  a n o t h e r  
m o l e c u l e  o f  t h e  a c e t o x y p i p e r i d i n e  t o  f o r m  t h e  s a l t .  T h e  
s m a l l  q u a n t i t y  o f  s a l t  i s o l a t e d  c o m p a r e d  w i t h  t h e  m u c h  
l a r g e r  p r o p o r t i o n  o f  t e t r a h y d r o p y r l d i n e  i n d i c a t e d ,  h o w e v e r ,  
t h a t  t h e  b u l k  o f  t h e  t e t r a h y d r o p y r l d i n e  m u s t  b e  f o r m e d  
d u r i n g  t h e  r e a c t i o n  o r  t h e  s u b s e q u e n t  d e c o m p o s i t i o n  o f  t h e  
G r i g n a r d  c o m p l e x ,  a n d  n o t  b y  d e c o m p o s i t i o n  o f  t h e  e s t e r  
d u r i n g  d i s t i l l a t i o n *  W h e n  t h e  r e a c t i o n  w a s  r e p e a t e d  u n d e r  
m i l d e r  c o n d i t i o n s ,  h o w e v e r ,  p r a c t i c a l l y  n o  a c e t y l a t i o n  
o c c u r r e d  a n d  t h e  p r o d u c t  w a s  m a i n l y  t h e  h y d r o x y p i p e r i d i n e  
( X X X I V ) ; t h o u g h  t h e  i s o l a t i o n  o f  a  s m a l l  q u a n t i t y  o f  
2 : 2  ; 6 - t r i m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p l p e r l d i n e  a c e t a t e  
( a c e t a t e  o f  X X X I V )  f r o m  t h e  p r o d u c t  a f t e r  d i s t i l l a t i o n  
i n d i c a t e d  t h e  f o r m a t i o n  o f  a  s m a l l  q u a n t i t y  o f  t h e  u n s t a b l e  
e s t e r  i n  t h e  r e a c t i o n .
A n  I n t e n s i v e  e f f o r t  t o  o b t a i n  e s t e r s  o f  1 : 2 : 2 : 6 -  
t e t r a m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  w a s  s t i l l  l e s s  
s u c c e s s f u l .  T r e a t m e n t  o f  t h i s  a l c o h o l  ( X X X V )  w i t h  a c e t i c
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a n h y d r i d e  a l o n e  o r  i n  t h e  p r e s e n c e  o f  a n  i n e r t  d i l u e n t  
f a i l e d  t o  p r o d u c e  a n y  r e a c t i o n  a t  t e m p e r a t u r e s  u p  t o  1 0 0 ° :  
t h e  a d d i t i o n  o f  b a s i c  o r  a c i d i c  c a t a l y s t s  ( p y r i d i n e ,  
s o d i u m  a c e t a t e  o r  s u l p h u r i c  a c i d )  r e s u l t e d  i n  f o r m a t i o n  
o f  t h e  t e t r a h y d r o p y r i d i h e  ( X X X V I  o r  X X X V I I ;  R  =  M e )  i n  
v a r y i n g  a m o u n t s . A c e t y l  c h l o r i d e  b r o u g h t  a b o u t  d e h y d r a ­
t i o n  m o r e  r a p i d l y  t h a n  a c e t i c  a n h y d r i d e  u n d e r  c o r r e s p o n d i n g  
c o n d i t i o n s .  T r e a t m e n t  o f  t h e  G - r i g n a r d  c o m p l e x  f o r m e d  
f r o m  1 : 2 : 2 : 6 ~ t e t r a m e t h y l - 4 - p h e n y 1 - 4 - h y d r o x y p i p e r i d i n e  a n d  
e t h y l m a g n e s i u m  b r o m i d e  w i t h  a c e t i c  a n h y d r i d e  a l s o  g a v e  a  
m i x e d  p r o d u c t  c o n t a i n i n g  v a r y i n g  a m o u n t s  o f  t h e  t e t r a h y d r o ­
p y r l d i n e  : t h o u g h  t h e  i s o l a t i o n  o f  a  s m a l l  q u a n t i t y  o f  a
d e l i q u e s c e n t  s a l t  i n  o n e  c a s e  s u g g e s t e d  t h e  f o r m a t i o n  a n d  
s u b s e q u e n t  s p o n t a n e o u s  d e c o m p o s i t i o n  o f  a  s m a l l  q u a n t i t y  o f  
t h e  d e s i r e d  e s t e r .
1 : 2 : 2 : 6 - t e t r a m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  w a s  u n ­
e x p e c t e d ,  a s  t h e  p r e p a r a t i o n  o f  a  n u m b e r  o f  s i m i l a r  p h e n y l -
T h e  d i f f i c u l t y  o f  e s t e r i f y i n g  2  : 2 : 6 - t r i m e t h y l -  a n d
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p i p e r i d o l  e s t e r s  h a s  b e e n  r e p o r t e d .  J e n s e n  a n d  L u n d q u i s t  
o b t a i n e d  t h e  m e t h y l ,  e t h y l  a n d  p r o p y l  e s t e r s  o f  1 - m e  t h y 1 - 4 -  
p h e n y 1 - 4 - h y d r o x y p i p e r i d i n e  ( X X I V ;  R  *  M e ) ,  t h e  t w o  l a t t e r
?h OH ph, OH Ph CM
> - /"X/ \ \
? 1 I : |
I I  I 1 !x , 'x ■ i \ .' ' \
^ X  1 ^  H AX-s-i X i - h  Xl."
b y  t h e  u s e  o f  t h e  a p p r o p r i a t e  a c y l  c h l o r i d e  i n  a n  i n e r t
4 4
s o l v e n t  ( e t h e r ,  a c e t o n e ) .  L e e  a n d  a s s o c i a t e s  , w o r k i n g  
o n  t h e  s a m e  p i p e r i d o l ,  f o u n d  t h a t  t h e  u s e  o f  a c y l  c h l o r i d e s  
t e n d e d  t o  p r o d u c e  d e h y d r a t i o n ,  b u t  c o n s i d e r a b l y  e x t e n d e d  
t h e  r a n g e  o f  e s t e r s  b y  t h e  r e a c t i o n  o f  a c i d  a n h y d r i d e s  
e i t h e r  o n  t h e  p i p e r i d o l  o r  o n  t h e  G r i g n a r d  c o m p l e x  f o r m e d  
f r o m  t h e  p i p e r i d o n e ,  a n d  b y  t h e s e  m e t h o d s  w e r e  a b l e  t o  
p r e p a r e  s e v e r a l  e s t e r s  ( e . g * ,  t h e  p h e n y l a c e t i c )  w h i c h
4 5
J e n s e n  a n d  L u n d q u i s t  f a i l e d  t o  o b t a i n .  T h e s e  w o r k e r s ^  
a l s o  o b t a i n e d  s i m i l a r  e s t e r s  o f  1 : 3 - a i m e t h y l - 4 - p h e n y l - 4 -
4 6
h y d r o x y p i p e r i d i n e  ( X X V I ) ,  w h i l e  G - . M .  B a d g e r  a n d  a s s o c i a t e s  
h a v e  r e c e n t l y  r e p o r t e d  t h e  p r e p a r a t i o n  o f  t h e  p r o p y l  e s t e r  
o f  t h e  v e r y  c l o s e l y  r e l a t e d  1 : 2 : 2 : 6 : 6 - p e n t a m e t h y 1 - 4 - p h e n y 1 -  
4 - h y d r o x y p i p e r i d i n e  ( X L I ) .  A l l  t h e  t e c h n i q u e s  e m p l o y e d  b y  
t h e s e  w o r k e r s  w e r e  u s e d  w i t h o u t  s u c c e s s  i n  a t t e m p t s  t o  
o b t a i n  e s t e r s  o f  2 : 2  : 6 - t r i m e t h y l -  a n d  1 : 2 : 2 : 6 - t e t r a m e t h y l - 4 -  
p h e n y  1 - 4 - h y d r o x y  p i  p e r  id. i n e  . T h e r e  I s  n o  d o u b t  t h a t  t h e s e
l a s t  t w o  p i p e r i d o l s  a r e  d e h y d r a t e d  w i t h  e x c e p t i o n a l  
f a c i l i t y ,  s i n c e ,  f o r  e x a m p l e ,  1 : 2  : 2  : 6 : 6 - p e n t a m e t h y 1 - 4 -  
p h e n y l - 4 - h y d r o x y  p i p e r  i d  i n e  w a s  s u c c e s s f u l l y  e s t e r i f i e d  b y  
t h e  a c t i o n  o f  a c e t y l  c h l o r i d e  i n  b e n z e n e  s o l u t i o n  o n  w a r m i n g ,  
a  p r o c e d u r e  w h i c h  i n  t h e  e a s e  o f  1 : 2 : 2 : 6 ~ t e t r a m e t h y 1 - 4 - p h e n y 1 -  
4 - h y d r o x y p i p e r i d i n e  r e s u l t e d  i n  v e r y  r a p i d  d e h y d r a t i o n .  
M o r e o v e r ,  t h e  e s t e i s ,  w h e n  f o r m e d ,  a p p e a r  t o  b e  p a r t i c u l a r l y  
u n s t a b l e , t h e  p r o p y l  e s t e r  o f  2 : 2 : 6 - t r i m © t h y 1 - 4 - p h e n y 1 - 4 -  
h y d r o x y  p i p e r i d i n e  d e c o m p o s i n g  o n  d i s t i l l a t i o n  i n  v a c u u m  
a n d  t h a t  o f  1 : 2 : 2 : 6 - t e t r a m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  
a p p a r e n t l y  d e c o m p o s i n g  s p o n t a n e o u s l y ,  w h e r e a s  t h e  m o r e  
s t a b l e  e s t e r s  o f  t h e  p i p e r i d o l s  o f  t y p e  ( X X I V )  c o n t a i n i n g  a  
b r a n c h e d  1 - a l k y l  c h a i n  ( e . g . ,  l - i s o b u t y l - 4 - p h e n y l - 4 -  
p r o p i o n o x y p i p e r i d i n e ) c a n  b e  d i s t i l l e d  w i t h o u t  c h a n g e .
T h i s  i n s t a b i l i t y  m a d e  t h e  i s o l a t i o n  o f  s m a l l  q u a n t i t i e s  o f  
t h e s e  e s t e r s  f r o m  t h e  a c c o m p a n y i n g  u n c h a n g e d  m a t e r i a l  a n d  
d e h y d r a t i o n  p r o d u c t s  i m p r a c t i c a b l e .
S p e c i m e n s  o f  2 : 2 : 6 - t r i m e t h y l -  a n d  1 : 2  : 2  : 6 - t e t r a -  
m e t h y l - 4 - p h e n y l - 4 - h y d r o x y p i p e r i d i n e  h y d r o c h l o r i d e s  h a v e  
b e e n  s u b m i t t e d  f o r  p h a r m a c o l o g i c a l  t e s t i n g .  A l t h o u g h  t h e  
a l c o h o l s  a r e  n o r m a l l y  m u c h  l e s s  a c t i v e  t h a n  t h e  c o r r e s p o n d i n g  
e s t e r s ,  n e v e r t h e l e s s  f r o m  a  k n o w l e d g e  o f  t h e i r  a n a l g e s i c  
p o t e n c y  ( i f  a n y ) ,  a n  e s t i m a t e  m a y  b e  o b t a i n e d  o f  t h e  t h e r a ­
p e u t i c  o r  d i s t h e r a p e u t i c  e f f e c t  o f  m e t h y l  s u b s t i t u e n t s  i n
the piperidine ring of compounds of this 4-phenyl-4- 
acyloxypiperidine type.
THE DECAHSTDROISOQUINOLINES.
The success of pethidine, and the identification 
of its 4-phenylpiperidine skeleton as a portion of the 
morphine molecule, in addition to giving a direct stimulus 
to work on piperidine derivatives, also led to the dissection 
of the morphine molecule into other fragments which might 
form the framework for further series of potentially active 
compounds. Of these, two related fragments which have re­
ceived some attention am the decahydroquinoline structure 
formed by rings 2 and 4 of morphine, and the octahydroiso- 
quinoline structure formed by rings 2 and 3.
On the quinoline model J.W. Cook^*^ and his 
associates prepared a number of 4-phenyl-l-ethyldecahydro- 
quinollne derivatives of type (XLII), the most active of 
which, 4-£*methoxyphenyl-l-ethyldecahydroquinoline, was
considerably less potent than pethidine.
fTist.
The corresponding 
(o h ) (om*)
XLII
compound without substituent in the phenyl ring had 
approximately the same activity, while the compound containing
m*.o --
a p-hydroxy substituent on the phenyl group was inactive.
Several workers have copied the isoquinoline model 
54Kulz and his associates claimed analgesic properties for
extensively substituted 1-arylalkyltetrahydroisqquinoline
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derivatives of type (XLIII), whose resemblance to morphine 
is obvious from the formula given, while Boekelheide^ 
prepared 10-phenyldecahydroquinoline (XLIV) as a simplified 
representation of the isoquinoline structure containing an 
angular aryl group formed by rings 1, 2, and 3 of morphine (I) 
The synthesis of a number of 2-alky 1-4-pheny 1-1- 
methyldecahydroisoquinolines (XLV) was planned as an extension 
of this work, and also the synthesis of a number of 1-benzyl -
2-alkyldecahydroisoquinolines (XLYI). These latter resemble 
particularly closely, in only slightly simplified form, a 
Ph
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Ph
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major portion of the morphine skeleton (I ; rings 1, 2 and 3)
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Adkins and Connor00, and more recently G-rundmann , 
have stated that copper chromite catalyst is ineffective
CQ
in bringing about the reduction of nitriles. Barr and Cook 
however, found that y-cyanoesters of type (XLVII) are
ft
i
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readily reduced by hydrogenation over this catalyst to give 
N-alkylpiperidines of type (XLIX), in which the N-alkyl 
group is provided by the alcohol used as solvent. Badger, 
Cook and Walker5^ confirmed this and extended the scope of 
the reaction* Prom the work of Barr and Cook (loc.cit*) 
and of Koelsch it is clear that the conversion of 
cyanoesters into N-alkylpiperidines proceeds in four stages
1) Reduction of the cyano group.
2) Intramolecular condensation with the elimination of 
alcohol to give the piperidone (XLVIII) which has 
been isolated in certain cases *
3) Reduction of the piperidone to the piperidine.
4) Alkylation of die piperidine by the alcohol used as 
solvent.
Thus it has been shown that not only can certain cyanides 
be reduced by the use of copper chromite catalyst, but that 
indeed this reaction provides a new and convenient method 
for the preparation of N-alkylpiperidines. Appropriate 
y' -cyanoesters were obtained by the Michael reaction, and 
thus it was possible to prepare, for example, 3 :4-diphenyl- 
1-alkylpiperidines in two operations from phenylaceto- 
nitrile and ethyl cinnamate.
Barr and Cook (loc.cit.) extended this method to the 
synthesis of a decahydroisoquinoline derivative by 
reductive-cyclisation of an appropriate cyano-ketone. 
1-AcetylcycIohex-l-ene 9 and phenylacetonitrile in the 
presence of sodium ethoxide condensed to give oe -2-acetyl- 
cyclohexylphenylacetonitrile (L), which on hydrogenation in 
ethanol over copper chromite catalyst underwent reductive- 
cyclisation to give a colourless liquid base; the com­
position of the base (and its picrate derivative) being in 
agreement with its identification as 4-phenyl-l-methyl~2- 
ethyldecahydroisoquinoline (LI). It was decided to repeat 
this work In order to confirm the identity of the product, 
and this having been satisfactorily achieved, to extend it 
to the synthesis of other N-alky1-4-pheny1-1-methyldeca- 
hydroisoquinolines by carrying out the hydrogenation In a 
variety of alcoholic solvents.
4-Phenyl-l~methyl~g~ethyldecahyd.roisoquinoline .
l-Acetylcyclohe x - l - e n e ^ * w a s  prepared from 
cyclohexene and acetyl chloride by the Friedel-Crafts’ 
reaction in carbon disulphide in the presence of stannic 
chloride, followed by elimination of hydrogen chloride from 
the intermediate chloro-ketone by refluxing with diethy1- 
aniline* The product was characterised by the semicarbazone,
O P I
m.p. 220 (decomp.) (Darzens records a melting point of 
220° for the semicarbasone). The oxime was also prepared* 
by refluxing l-acetylcyclohex-l-ene for 4 hours with an 
aqueous alcoholic solution of hydroxylamine hydrochloride 
and potassium hydroxide, and crystallised from aqueous 
methanol in colourless needles m.p. 61-62°. (Darzens
f t ' Z
and Wallach respectively record the melting point of the 
oxime as 90° and 99°.) This oxime appears to be the 
stereoisomer of that previously reported. It was unchanged 
when irradiated with ultra-violet light for 3 hours. The 
same product was obtained when acetylcyclohexene was treated 
with hydroxy lamine hydrochloride in pyridine at 100°. It 
may be noted that Wallach (loc.cit.) prepared the oxime in 
the cold.
The Michael condensation between acetylcyclohexene 
and phenylacetonitrile in the cold in presence of sodium 
ethoxide gave <<- -g-acetylcyclohexylphenylacetonitrile (I.) ,
m.p. 120°. (Barr and Gook^® record a melting point of 120°
L LI
f o r  - 2 - a c e t y l c y c l o h e x y l p h e n y l a c e t o n i t r i l e . ) .  T h i s  was 
f u r t h e r  c h a r a c t e r i s e d  b y  t h e  s e m i c a r b a z o n e , m.p. 2 2 9 - 2 3 0 °  
(decomp.).
Hydrogenation of a. -2-acetylcyclohexylphenyl- 
acetonitrile in ethanol over copper chromite catalyst 
(prepared as in Organic Syntheses^ except that the decom­
position of the complex was carried out by the original 
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Adkins method of heating over a free flame), gave a l i q u i d  
base distilling at 166°/2.5 mm., which was converted to the 
picrate. The picrate appeared to be a mixture, and this 
was confirmed when on fractional crystallisation from ethanol 
it was separated into two stereoisomeric compounds, fl,sL m-4- 
phenyl-l-methyl-2-ethyldecahydroigoquinoline picrate» m.p. 178- 
179°, and 1 a f>-4-phenyl-l-methyl-2-.ethyldecahydroisoquinoline 
picrate, m.p. 209-210° (decomp.). From the picrates were 
obtained the corresponding bases ( L I ) ,  * 1 - 4 -pheny1 - 1- m e thy1 -
2-ethyldecahydroisoquinoline, b.p. 155°/2 mm., and 1 J f-4-
pheny 1-1 -methyl - 2 -e thy Idecahydro Iso quinoline, b.p. 136°/1 
The base (b.p. 135°/l ram.) and picrate (m.p. 187-190°) 
reported by Barr and Cook (loc.cit.) obviously consisted of 
a mixture of these * aL * and »/3 1 isomers.
4-Phenyl-1-methylisoquino line.
In order to confirm the identity of the bases obtained 
above a portion of the mixed base was dehydrogenated by 
heating at 300-320° with palladium black catalyst. The 
product was identified by analysis and by melting point (78-79*)
Q C L
as 4-pheny 1-1-methy 1 isoquino 1 ine (Krabbe records a melting 
point of 79° for 4-phenyl-l-methylisoquinoline). The 
picrate was also prepared, and its composition confirmed by 
analysis, but the melting point, 229-230° (decomp.), is not 
in accordance with that recorded by Krabbe (loc.cit.), who 
records a melting point of 206° for 4-pheny1-1-methyliso- 
quinoline picrate.
Despite the divergent melting points of the picrates 
it was considered that the identity of the bases obtained by 
reductive-cyclisation of -2-acetylcyclohexylphenylaceto­
nitrile was substantially established by the above work, and 
the synthesis was extended to the preparation of other 
N -a Iky 1-4 -phenyl -1 -met hy lde c ahydro i s o qu inol ine s. Hydrogena­
tion of ao'etylcyc lohexylphenylace tonitri le in methanol gave
^ ’-and 1 p 1 -4-phenyl-1 ; 2-dime thyldecahydrolsoquinollnea 
(LIT/ R - Me) willcii were characterised as the corresponding 
p. picrates. through which salt the
gave 1 oc f- and 1 p 1 -4-phenyl- 1-methyl-2-n-propyldecahydro- 
isoquinolines (LII; R = n-Pr), separated and characterised 
as before by means of the picrates.
decahydroisoquinolines were obtained. The relative pro­
portions of the two isomers In the mixed basic product of 
the reduction reaction, as indicated by the amounts of the 
1 oL 1 and *p> 1 picrates Isolated, were not constant however, 
but appeared to vary regularly through the series of N- 
alkyldecahydroisoquinolines prepared. In the case of the 
N-methyldecahydroisoquinolines the approximate ratio was 
4. i « Isl ; for the N-ethyl compounds 4. 1 f> 88 2-3 : 1 
and for the N-n-propyl compounds 4. : p * 10 : 1. These 
ratios are approximate only, but they give an indication of 
the rapid decrease in the proportion of the 1 p * Isomer on 
ascent of the homologous series. The 'ft 1 Isomer cor­
responds to the picrate of higher melting point, and the
separation was achieved by fraction 
al crystallisation. Similarly, 
hydrogenation of a cetylcyclohexyl-
LII phenylacetonitrile In n-propanol
In each case, It will be noted, two stereoisomer!c
H*
base of (probably) lower boiling point# As eight optically 
inactive stereoisomeric forms of compounds of this type 
(LII) may be expected, it is not possible to define the 
configurations of these 1^ * and * p  f isomers•
The synthesis of N-alkyl-4-phenyl-l-methyldecahydroiso- 
quinolines by the reductive-cyclisation of oxime-esters.
Badger, Cook and Walker^ showed that suitable 
oxime-esters could be reduced to N-alkylpiperidine deriva­
tives in a very similar manner to the -g -cyanoesters above. 
For example, these workers obtained 4-phenyl-l-ethyldeca- 
hydroquinoline (LIV) in satisfactory yield by the reductive-
N O H
LIII LIV
cyclisation of the oxime of ethyl /3 -2-ketocyclohexyl-0 - 
phenyIpropionate (LIII) in ethanol in presence of copper 
chromite catalyst. The possibility of synthesising N- 
alkyldecahydroisoquinolines by this method was therefore 
investigated.
o L  -2-Acetylcyclohexylphenylacetonitrlle (L) was 
hydrolysed with alcohol aid sulphuric acid to give
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ethyl- «c-2-acetyIcyclohesyIphenylacetate (LV) - The 
identity of this product was confirmed by alkaline hydrolysis 
to the acid (LVIII) and comparison with an authentic speci­
men of o L  -2-acetylcyclohexyIpheny lacetic acid prepared 
directly by alkaline hydrolysis of <*. -2-acetylcyclohexyl- 
phenylacetonltrile. In this latter hydrolysis a quantity 
of non-acidic material was also isolated, which appears to 
be 4-phenyl-l-methyl-5:6 ;7:8:9 ;10-hexahydro-5-isoquinolone 
(LVII), formed evidently by intramolecular cyclisation of 
the intermediate amide with elimination of the elements of 
water* A similar cyclic product was obtained in the con-i
dens it ion of malonamide with 1-phenylaoetylcyclohex-l-ene
(p.61).
All attempts to obtain a crystalline oxime (LVI) 
of ethyl d .  -2-acetyloyclohexyIphenylacetate were unsuccessful, 
the product invariably being an oil. This crude product 
was therefore submitted to hydrogenation in methanol over 
copper chromite catalyst. Methanol was preferred as sol­
vent because the preceding series of experiments on the 
reduction of cyanoesters had shown that the two possible 
stereoisomeric decahydroisoquinolines were obtained in 
approximately equal quantities when the reduction was carried 
out in methanol, whereas when higher alcohols were used the 
proportion of the •jS 1 isomer of the decahydro isoquinoline 
decreased considerably: and it was therefore considered
that the probability of isolating both isomers, should these 
actually be formed in the reduction of the oxime-esfeer>.
would be ehhanced by carrying out the reduction in methanol.
58Barr and Cook have shown that when the reduction of cyano­
esters is carried out in an inert solvent such as dioxane 
the small amount of alcohol formed during the cyclisation 
is sufficient to cause partial alkylation of the product:
e. - Nan
LVI LI
but it was considered that the small amount of ethanol
produced in the reductive-cyclisation of this oxime-ester 
(LVI) would be insignificant compared with the large volume 
of methanol used, and this proved to be the case. The 
small yield of basic material from the reduction was 
fractionally distilled, and the first fraction was identified 
by means of the picrate as the ' p  1 isomer of 4-phenyl-l :2- 
dime thyldecahydroisoquinoline (LIX). Strangely enough,
this product appeared to be homogeneous, and unaccompanied 
by the * oC * isomer which would certainly have been detected 
had it been present in any significant proportion-
now insoluble in dilute hydrochloric acid, solidified, and 
by fractional crystallisation was separated into two isomeric 
components. In view of the acid-Insolubility of these 
compounds, and the fact that reductive-cyclisations of this 
type are known to proceed by way of the piperidones (Barr
CO C<1
and Cook ; Badger, Cook and Walker ), these two compounds 
are regarded as isomeric 4-phenyl-l-methyldecahydro-5- 
lsoquinolones (LXI). These are evidently formed during
Hi j C*. -C/^TTVM-t.
Vt^tLl'vvxA.
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The second fraction of the distillate, which was
55.
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distillation, by intramolecular cyclisation with elimina­
tion of the elements of water from the acid-soluble amine - 
ester (LX). The two isomers are probably of the same 
type as those of the decahydroisoquino 1 ines previously en­
countered .
The isolation of two stereo isomeric forms of these 
N-alkyl-4-pheny 1-1 -methyldecahydroisoquino 1 ines (LII) from 
the reductive-cyclisation of the cyano-ketone < * .-2-acetyl
cjclohexy Ipheny lacetonitrile, and of two stereo isomeric 
forms of the intermediate 4-phenyl-l-methyldecahydro-3- 
isoquinolone (LXI) from the reductive-cyclisation of the 
oxime-ester (LVI) is of some interest, as it will be re-
LII LXI
53called that Badger, Cook and Walker isolated only one 
isomer of 4-phenyl-1-ethyldecahydroquinoline (LIV)
following similar hydrogenation of the oxime-ester (LIII;
P hi
X. -  C-H 04^. (Lcrctt
= Now
\ / v i/ 
it
LIII LIV
oxime of ethyl f i -2-ketocyclohexyl- ft -phenylpropionate). 
The yield in this case was approximately 60$, hut the 
stereochemical homogenie ty of the product was remarked 
upon* The same authors also obtained 4-p-msthoxyphenyl- 
1-ethyldecahydroquinoline, by a similar method, in 70$
yield free or almost free from stereoisomer*. On the
58other hand, Barr and Cook isolated two stereo isomeric
3 :4^diphenyl-l-ethylpiperidines (XLIX) from the similar
P h  Ph
* i
PL
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reductive-cyclisation of ethyl- # -cyano-/J# -diphenylbutyr- 
ate (XLVII)*
Specimens of 2-methyl-4-phenyl-l-methyldecahydro- 
isoquinoline, 2-ethy 1-4-pheny 1-1-methyldecahydroisoquinoline 
and 2-n-propyl-4-pheny 1-1-me thyldecahydroisoquinoline, in
the form of aqueous solutions of the hydrochloride of the 
mixed isomeric bases, were submitted for pharmacological 
testing*
The condensation of 1-acetylcyclohex-l-ene with ethyl phenyl
acetate.
It was thought that ethyl -2-acetylcyclohexyl- 
phenylacetate (LV) might be more readily available by 
direct Michael condensation of acetyloyclohexene and ethyl 
pheny lac et ate. In point of fact, however, a Perkin type
condensation appeared to be favoured. None of the desired 
keto-ester was obtained, but the solid product of the re­
action was separated by fractional crystallisation into two 
isomeric compounds of melting point 198° and 170° respective 
ly, both of which gave dioxime derivatives. Microhydro­
genation over Adams* catalyst in acetic acid resulted in 
an absorption of hydrogen equivalent to 6*05 and 5.9 double
Ph
i
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bonds per molecule respectively. As it was not possible 
to isolate and identify the products of 1he microhydrogena­
tions, the identity of these condensation products could
58.
not be established, but formulae (LXII) and (LXIII) are 
suggested as possible struetures for these products•
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N ~Alkyl-1-benzyldecahyd.rois oquinoline a *
It was planned to extend tills method of reductive- 
cyclisation to the synthesis of N-alkyl-l-benzyldecahydro* 
isoquinolines of type (LXVII) from cyano-ke tones of type 
(LXV), an obvious route to tiie desired cyano-ketone being
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the Michael condensation of 1-phenylacetylcyclohex-l-ene 
(LXIV) with ethyl cyanoacetate, followed by hydrolysis of 
the ester group of the product (LXV) and decarboxylation* 
1-Fheny lac etylcyclohex-l-ene was prepared by the 
Friede 1-Crafts 1 reaction between cyclohexene and phenyl- 
aeetyl chloride in carbon disulphide in the presence of 
stannic chloride, followed by elimination of hydrogen 
chloride from the intermediate ehloro-ketone by refluxing
art ‘
with die thy lanl line (Cook )• By using an excess of cyclo- 
hexene in the condensation the yield of pheny lac etylcyclo-
hexene with respect to the less readily available starting 
material, phenylacetyl chloride, was improved considerably.
The condensation between phenylacetylcyclohexene and 
ethyl cyanoacetate In the presence of sodium ethoxide 
appeared, however, to take place by the Perkin method rather 
than the Michael, and none of the desired condensation pro­
duct (LXV) was isolated# The solid product of the reaction, 
which appeared to be homogeneous, contained no ethoxyl group. 
No derivative (oxima, semicarbazone or dinitrophenylhydra- 
zone) of a ketonic function could be obtained, but treatment 
with acetic anhydride yielded a diacetyl derivative. Micro­
hydrogenation over Adams* catalyst in acetic acid, assuming
a molecular weight of 267, indicated the presence of 3 double 
bonds per molecule, but it was not possible to isolate and 
identify the product of the microhydrogenation. The 
identity of the condensation product therefore could not be 
established, but it is suggested that the structure may be 
of the type (LXVIIIa) or (LXVIIIb).
u
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In both cases, therefore, where an ester was
condensed with an acyIcyclohexene it was found that a Perkin 
type condensation appeared to he favoured in preference to 
the Michael* To avoid this difficulty the practicability 
of using compounds such as malonamide and cyanoacetamide 
which do not contain an ester grouping, in place of ethyl 
cyanoacetate, was investigated.
gQ
Malonamide , prepared from diethylmalon&te and 
aqueous ammonia, condensed with l-phenylacetylcyclohex-l-ene 
on re fluxing in ethanol in the presence of sodium ethoxide, 
to give a colourless crystalline product in 38$ yield.
This product, however, proved on analysis to be not the
ph
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simple Michael addition product (LXIX), but 1-benzyl- 
5:6:7:8 :9:10-hexahydro-3-lsoquinolone-4-oarboxyamide (LXX), 
evidently formed from the Michael addition product by intra­
molecular cyclisation with elimination of the elements of 
water. (A similar cyclisation occurred during the hydrolys 
is of o L -2-acetylcyclohexy Ipheny lacetonitrile, p* 52 )•
The possibility of this cyclisation was foreseen, and the
cyclic product was not considered disadvantageous for the 
purposes of the synthesis.
Treatment of this compound (LXX) in cold concen­
trated sulphuric acid with sodium nitrite solution
go
(Bduveault ) was completely ineffective in converting the 
amide group to carboxyl. When, however, the compound was 
dissolved in 40$ sulphuric acid at 100° and then t reated 
with sodium nitrite solution (Gatterman*^; Biltz and 
Kamman^) the desired acid, 1-benzyl-5:6 :7:8 :9 tlO-hexahydro-
3-isoquinolone-4-carboxylic acid (LXXI) was obtained in 
excellent yield. This acid then readily underwent de-
CH. Ph
,N
Ph h
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carboxylation when heated a few degrees above the melting 
point, to give l-benzyl-5:6 :788:9:10-hexahydro-5-iso- 
qulnolone (LXXII).
This isoquinolone, however, proved completely 
resistant to hydrogenation over copper chromite catalyst, 
and was recovered unchanged after being submitted to hydro­
genation in ethanol for 4 hours at 200° and 180 atm., the
60
most severe conditions obtainable. Koelsch , synthesising
substituted piperidines, used sodium in boiling butyl al­
cohol to reduce pyridine derivatives to the corresponding 
piperidines, and also to reduce piperidones to piperidines. 
This method was therefore applied to 1-benzyl-5:6 :7 :8:9:10- 
hexahydro-5-isoqulnolone, and from the reduction product a
N H
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small yield of a colourless, liquid base was isolated, which 
was converted to the hydrogen oxalate and Identified as 
1-benzyldecahydroisoquino1ine hydrogen oxalate (hydrogen 
oxalate of LXXIII). A small quantity of non-basic oil 
which m s  also isolated appeared to be an intermediate 
product of the reduction.
Cyanaeetamide^®, prepared from ethyl cyanoacetate 
and aqueous ammonia, also condensed with 1-phenylacetyl- 
cyclohex-l-ene on refluxing in ethanol in the presence of 
sodium ethoxlde. In this case the normal Michael addition 
product, pi-2-phenylacetylcyclohexylcyanoacetamlde (LXXIV) 
was obtained in 21$ yield, and no cyclic product corresponding
/ X
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to that (LXX) obtained from the condensation of phenyl-
acety Icy clohexene and malonamide was observed.
As was the case with the cyclic malonamide conden-
69sation product (LXX), the Bouveault method was ineffective
in converting this amide to the corresponding acid. When 
70 71the Gatterman 9 method was used this amide proved very 
sparingly soluble in dilute sulphuric acid, and it was 
necessary to carry out the reaction in 50$ sulphuric acid 
at 140° to maintain the amide in solution: under these
conditions a vigorous reaction ensued on addition of sodium 
nitrite solution. Prom the product of the reaction were 
isolated a quantity of unchanged d  -2-phenylacetylcyclo- 
hexylcyanoaeetamide (30$) and an acid (50$), which, however, 
proved to be not the expected d  -2-phenylacetylcyclohexyl-
<X
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cyanoacetic acid (LXXV), but the cyclic product 1-benzyl- 
5 :6 :7:8 :9:10-hexahydro-3-isoquinolone-4-carboxylie acid 
(LXXI) identical with that previously obtained by the action 
of sodium nitrite on 1-benzy 1-5:6 :7:8:9 :10-hexahydro-3- 
isoquinolone-4-.car boxy amide (LXX), the cyclic product of the
condensation of malonamide and pheny lac e ty ley clohexene«
The identity of the acid was confirmed when on decarboxyla­
tion it gave 1-benzyl-5:6 :7s8:9:10-hexahydro-3-isoquinolone 
(LXXII) identical with that obtained previously.
Two possible routes may be suggested to account for 
the formation of this cyclic acid (LXXI) • Under the rather 
severe conditions of the Gatterman reaction -2-phenylacetyl 
oyelohexylcyanoacetamide may undergo intramolecular
/ X - ™ .
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cyclisation with elimination of water to form the cyclic 
nitrile (LXXVI), followed by hydrolysis of the nitrile 
group to give the cyclic amide (LXX), which, as has already 
been shown, reacts readily with nitrous acid to give 
l-benzyl-5:6 :7 :8 :9 :10-hexahydro-5-isoquinolone-4-carboxylic 
acid. Alternatively, hydrolysis of the nitrile group of 
< <  -2-phenylac etylcyelohexylcyanoacetamide may occur first 
to give the di-amide (LXIX) which is known from the previous
/V
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experiments to cyclise readily under comparatively mild 
conditions to give the cyclic amide (LXX), which reacts 
with nitrous acid to give l-benzyl-5:6 :7:8 :9:10-hexahydro-
3-isoquinolone-4-earboxylie acid. The relative resistance
of the cyano-amide '(LXXIV) to cyclisation, as evidenced by 
the structures of the products of the Michael reactions of 
phenylace ty 1 eye lohexene with malonamide and eyanoacetamide 
respectively, and the fact that the non-acidic portion of 
the product of the Gatterman reaction consisted entirely 
of unchanged phenylacetylcyclohexylcyanoacetamide and no 
evidence of any intermediate such as the cyclic nitrile 
(LXXVI) was found, strongly support the second hypothesis.
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Section I.
The Bisdlalkylaminoalkylnaphthalenes.
1:4-Bis chlorome thy lnaphthalene (XXII) : 1 ^-Bischloromethyl-
naphthalene was prepared by the chlorome thylat ion of
naphthalene with boiling aqueous formaldehyde and hydro-
41 ochloric acid . The reaction product, m*p. 120-130 , was
crystallised from ethanol to a melting point of approximate­
ly 132°, and this semi-pure material was used in the sub­
sequent experiments*
1 :4-Bis thioc arbamidomethy lnaphthalene (XIX): 144-Bis -
chloromethylnaphthalene (2*0 g*) was dissolved in dry 
benzene (25 c*c.) and heated to boiling; a solution of 
thiourea (1.5 g.) in ethanol (30 c*c*) was added dropwise.
A colourless precipitate formed immediately, and the mixture 
was refluxed for a further 30 minutes, nhen the reaction 
appeared complete. The mixture was then cooled and the 
solid product, 1 :4-bis thiocar bamidome thy lnaphthalene hydro­
chloride , filtered off and crystallised from dilute hydro­
chloric acid in small colourless needles (0*9 g*), m*p. 270- 
271° (decomp*)•
' * ■ [ Pound : G, 44*8; H, 4*6; N, 14*5 1
C14H18N4S2C12 re<luires 5 c > 44*6; H, 4*8; N, 14*8$).]
The pi orate was prepared from the hydrochloride in aqueous 
solution, and crystallised from acetone in yellow needles, 
m*p* 219-220° (decomp*.).
Pound : C, 41*2; H, 3*0 
C32H22°14N 10S2 re<iuires 5 G > 41*0; H, 2.9$
1 :4 -Blsdie thy laminomethy lnaphthalene (XX): l-»4-Bischloro-
me thy lnaphthalene (1*5 g*) was dissolved in dry benzene 
(25 c.c.) and heated to boiling; diethylamine (2*2 g.) in 
dry benzene (10 c.c.) was added dropwise and the mixture 
refluxed for 10 hours. After cooling the mixture was 
shaken with concentrated sodium hydroxide solution, the 
benzene layer separated and the aqueous portion extracted 
with benzene. The combined benzene solution was dried over 
anhydrous sodium sulphate, and evaporated, and the oil ob­
tained was heated at 100° for 1 hour to remove excess di­
ethylamine. The oil was then dissolved in benzene and 
extracted with dilute hydrochloric acid, the acid extract 
basified with sodium hydroxide solution, and extracted with 
benzene. This benzene extract was dried over anhydrous 
sodium sulphate and evaporated, and the oil obtained was 
distilled at 168-170°/1 m.m*, giving a slightly cloudy ,, 
colourless oil (0*8 g*), which darkened on standing.
1 :4-Bisdie thy laminome thy lnaphthalene hydrochloride, prepared 
from this base in ether solution, crystallised from
ethanol/sther in small colourless needles, ni.p. 228-229° 
(decomp.)*
Pound : C, 63.1; H, 8.3; N, 7.0
°20H32N2C12 re<3.uires : G > 63.2; H, 8.6; N, 7.3$
The plcrate, prepared from the base In ethanol solution, 
crystallised from acetic acid in yellow needles, m.p. 203- 
204° (decomp.).
Found : C, 50.7; H, 4.6; N, 14.9
g32h 36°14% re(iuires : C, 50.8; H, 4.8; N, 14.8$
1<4-Bis-N-piperidylmethylnaphthalene (XXI): 1 :4-Bischloro-
methylnaphthalene (3.0 g.) was dissolved in dry benzene 
(25 c.c.) and heated to boiling; to this a solution of 
piperidine (5.0 g.) in dry benzene (20 c.c.) was added drop- 
wise. A colourless crystalline precipitate began to form 
immediately, and the mixture was refluxed for a further 40 
minutes, when the reaction appeared complete. After 
cooling the mixture was shaken with sodium hydroxide solution, 
the benzene layer separated, and the benzene washings of the 
aqueous layer added to this. The benzene solution was then 
dried over anhydrous sodium sulphate and evaporated, and the 
oil obtained was heated at 140G/l4 m.m. for 1 hour to remove 
excess piperidine. The oil was then dissolved in benzene 
and extracted with dilute hydrochloric acid, the acid extract 
basified with sodium hydroxide solution and extracted with
benzene. This extract, dried over anhydrous sodium sul­
phate and evaporated, gave a light brown oil, which decom­
posed slightly at 200°/l4 m.m. without distilling, and was 
purified by chromatography through alumina; the pale yellow 
product partly solidified. 1:4-Bis-N-piperidylmethy1-
naphthalene hydrochloride was prepared from this base in 
ether, and crystallised from ethanol in colourless plates, 
m.p. 305-306° (decomp.).
j Pound : C, 66*9; H, 8.2; N, 6.9
!1
LC22H32N2C12 requires : C, 66.8; H, 8.1; N, 7.1$
Prom this hydrochloride was obtained the base, l:4-bis-N- 
piperidylmethylnaphthalene, which crystallised from efhanol 
in colourless prisms m.p. 135-136°.
( Pound : C, 82.$ H, 9.3; N, 8.7
i
[ C22h 30N2 requires : C, 82.0; H, 9.3; N, 8.7$
Attempted condensation of 1 ;4-bis chlorome thy lnaphthalene and
tetramethylthiourea.
1 :4-Bischlorome thy lnaphthalene (5.0 g.) was dissolved 
in dry xylene (25 c.c.) and the solution heated to boiling; 
the theoretical quantity of tetramethylthiourea (5.25 g.) 
in dry xylene (25 c.c.) was added dropwise and the solution 
refluxed for 15 hours. A quantity of colourless solid 
separated during this time and was filtered from the cold 
solution; a small additional quantity was obtained after a
further 6 hours’ refluxing. This solid was deliquescent, 
and its aqueous solution was proved to contain chloride 
ion: it was therefore presumed to be the methochloride of
either tetramethylthiourea or the desired condensation 
product. The compound decomposed on distillation to give 
tetramethylthiourea, m.p. 79° (after crystallisation from 
petroleum ether), which was identified by comparison with 
an authentic specimen, thus confirming its identification 
as the methochloride of tetramethylthiourea. The xylene 
solution after the removal of this solid was extracted with 
dilute hydrochloric acid, the acid extract basified with 
sodium hydroxide solution, and extracted with benzene.
This extract was dried over anhydrous sodium sulphate and 
evaporated, to give a small yield of an oily solid, presum­
ably a mixture of the desired condensation product and un­
reacted tetramethylthiourea, which started to decompose on 
distillation, and could not be separated.
In another experiment the reaction mixture, after 
being refluxed for 21 hours, cooled and filtered, was allowed 
to stand at room temperature for 1 month. A further quanti­
ty of the methochloride separated, but again no product could 
be isolated from the residual solution.
Section 2.
The 4-Phenyl-4-hydroxypiperidines.
2 :2:6-Trimethyl-4-piperidone (XXXIII): 4-Amino-4-
methylpentan-2-one (diacetonamine) was prepared by condens­
ing mesityl oxide with aqueous ammonia in the cold, and
isolated as the hydrogen oxalate^®. This condensed with
49acetal in ethanol solution to give the hydrogen oxalate 
of 2 :2 :6-trime thy1-4-piperidone (vinyldiacetonamine), from 
which the base 2 :2 :6-trim©thy1-4-piperidone was extracted.
2:2:6-Trimethy1-4-phenyl-4-hydroxypiperidine (XXXIV): To
a Grignard solution prepared in the usual way from bromo- 
benzene (66.8 g.), magnesium (10.2 g.) and ether (150 c.c.), 
a solution of 2 :2 :6-trimethyl-4-piperidone (20 g.) in ether 
(25 c.c.) was added dropwise with stirring. When the 
vigorous reaction had subsided the solution was refluxed 
for 1 hour, cooled, and the complex decomposed by pouring 
into a mixture of ice and aqueous ammonium chloride solution 
(100 c.c.). After standing overnight the solid was filtered, 
dried, and washed with ether; the product was then extracted 
from the accompanying magnesium hydroxide with hot ethanol, 
and crystallised from ethanol/ek*161* 111 colourless prisms, 
m.p. 250-251° (decomp.). Prom this hydrochloride by basifi- 
cation with sodium hydroxide solution and extraction with 
ether was obtained the base, 2 :2:6-trimethy 1-4-phenyl-4-
hydroxypiperidIne, which crystallised from 80/100° petroleum
The hydrochloride, prepared from the base in ether solution,
During the preparation of this hydrochloride a small quanti­
ty was Isolated of another material, which ciystallised
(decomp*), and was identified by comparison with an authentic 
specimen as 2 :2:6-trimethyl-4-phenyl-1:2:5:6 (or 1:2:3 :6)- 
tetrahydropyridine hydrochloride (see below). This was 
evidently derived by dehydration of the 2:2:6-trimethyl-4- 
pheny 1-4-hydr oxypiperidine •
The picrate, prepared from the base in ether solution,
The hydrogen oxalate, prepared from the base in ether solution, '!
ether in colourless needles, m*p* 91-92° (13.0 g*) 
Found : C, 76.7; H, 9.9; N, 6.6
G14H210N requires : G, 76*7; H, 9.6; N, 6.4$
crystallised from ethanol/ether in colourless prisms 
m.p. 247-248° (decomp.).
Found : C, 65.8; H, 8.5; N, 5.7
from ethano3/e^ er *n colourless prisms, m.p. 266-267°
crystallised from water in yellow prisms, m.p. 188-189 
(decomp.).
o
Found : C, 53.6; H, 5.4; N, 12.8 
c 20h 24°8n4 requires : G, 53.6; H, 5.4; N, 12.5$
crystallised from ethano3/ether in small colourless needles, 
m.p. 201-202° (decomp.).
Found : C, 62.2; H, 7.5; N, 4.8
C16H23°5N requires : C, 62.1; H, 7.4; N, 4.5$
The acetate crystallised from acetone in colourless prisms, 
m.p. 223-224° (decomp.).
Found : C, 69.2; H, 8.9; H, 5.2
c16h25°3n requires : C, 68.8; H, 9.0; N, 5.0$
The product, m.p. 250-251°, isolated directly from 
the Grignard reaction, was proved by comparison with an 
authentic specimen to be essentially the hydrochloride of 
2 :2:6-trimethyl-4-phenyl-4-hydroxypiperidine. The analysis, 
however (Found : G, 57.0; H, 7*2; U, 5.4$), did not
correspond, and varied appreciably with different specimens: 
no reason for this m s  found. Increasing the time of re- 
fluxing increased slightly the yield of this material from 
the reaction, but also promoted the formation of other 
products which rendered isolation of the pure base more 
difficult.
When 2:2:6-trimethyl-4-phenyl-4-hydroxypiperidine was 
distilled (107-110°/l.5 m.m.) some dehydration occurred.
The product from distillation, or from refluxing in ethanol 
solution for 5 hours, crystallised from petroleum ether in 
colourless prisms, m.p. 96-97°. This appears to be a
crystalline modification of the original base. It did 
not depress the melting point of the original base, and 
on repeated crystallisation reverted to the original 
form, colourless needles f m.p. 91-92°.
2 :2 :6-Trimethyl-4-phenyl-4-hydroxypiperidine did 
not give a urethane derivative on treatment with phenyl- 
isocyanate. Dehydration of the alcohol occurred and 
carbanilide, formed by reaction of the phenylisocyanate 
with water eliminated from the alcohol, was isolated.
2 :2:6-Trimethyl-4-pheny1-1:2:5:6 (or 1 :2:3:6)-tetrahydro- 
pyridine (XXXVI or XXXVII; R = H) : 2:2:6-Trimethyl-4-
phenyl-4-hydroxypiperidine (1.75 g.) in ethanol (15 c.c.) 
was saturated with hydrogen chloride and heated at approxi­
mately 80° for 6 hours, during which time the solution was 
periodically resaturated with hydrogen chloride. The 
solution was then cooled, basified with dilute sodium 
hydroxide solution, and extracted with ether. The extract 
was dried over anhydrous sodium sulphate, evaporated, and 
the oil obtained distilled at 90-95°/0.5 m.m. to give a pale 
yellow oil (1.5 g.) which darkened rapidly on exposure to 
air. The hydroohloride was prepared from this base in 
ether solution, and crystallised from ethanol/ether in colour­
less prisms, m.p. 266-267° (decomp.).
Found : C, 70.6; H, 8.3; N, 6.1
G14H20N squires : C, 70.8; H, 8.4; N, 5.9$
The hydrogen oxalate was prepared from the base in ether 
solution, and crystallised from ethanol/ether in colour­
less prisms, m.p. 207-208° (decom.).
Found : C, 65.8; H, 6.9; N, 5.1
Ci6H2i04N requires : C, 66.0; H, 7.2; N, 4.0$
The picrate was also prepared, but could not readily be
separated from that of the unchanged alcohol with which 
it was contaminated.
Attempted etherification of 2 :2 s6-trime thyl-4-phenyl-4- 
hydroxypiperidine (XXXIV).
With alcohol and acid catalyst: 2:2:6-Trimethyl-4-phenyl-
4-hydroxypiperid3ne (0.2 g.) was dissolved in methanol 
(1 c.c.) and concentrated sulphuric acid in methanol 
solution was added till the mixture was slightly acidic. 
The mixture was then allowed to stand at room temperature 
for 2 hours, then basified with sodium hydroxide solution 
and extracted with ether. From this ether extract only 
unchanged starting material (0.1 g.) was isolated.
Under the same conditions, when methanol saturated 
with hydrogen chloride was used in place of the sulphuric 
acid solution, a mixed product resulted which could not be 
separated. When the time of reaction was increased to 6 
hours the only product isolated was 2:2:6-trimethyl-4-
phenyl-1 :2 :5:6 (or 1 :2 :3:6)-tetrahydropyridine, identified 
by comparison with an authentic specimen. .
Identical results were obtained using ethanol in 
place of methanol.
By dimethyl sulphate on the Grlgnard complex: 2:2 ^ -Tri­
ms thy1-4-piperidone (5.0 g.) was reacted as before with a 
Grignard solution (50$ excess) prepared from bromobenzene
I : - :
(16.7 g.), magnesium (2.55 g.) and ether (75 c.c.), and 
the solution refluxed for 8 hours. The solution was then 
cooled and the theoretical quantity of dimethyl sulphate 
(13.4 g.) in ether (30 c.c.) added dropwise with stirring. 
After the addition was complete the solution was refluxed 
for 1 hour, then cooled and decomposed with ice and aqueous 
ammonium chloride. The solid product (7.6 g.) was filtered, 
washed with ether and crystallised from ethanol/ether in 
colourless prisms, m.p. 250-251° (decomp.). By comparison 
with an authentic specimen this was identified as the 
hydrochlor ide of 2:2:6-trime thyl-4-phenyl-4 -hydroxypipe ridine. 
A further quantity (1.9 g.) of 2 :2 :6-trime thy 1-4-phenyl-4- 
hydroxypiperidine was obtained on basif ication of the 
aqueous liquor•
In another experiment the reaction of the pipe ridone 
with the Grigaard solution was carried out as above. To
this solution in the cold was then added 150$ excess of 
dimethyl sulphate (33.5 g.) in benzene (100 c.c.), the 
mixture refluxed for 10 hours, then cooled and decomposed 
with ice and aqueous ammonium chloride as before- No 
solid separated. Basification of the aqueous portion of 
the liquor with sodium hydroxide solution and extraction 
with ether yielded a small quantity of basic oil. Ex­
traction of the organic portion of the liquor with dilute 
hydrochloric acid, followed by basification of the acid 
extract with sodium hydroxide solution and extraction with 
ether gave a brown basic oil (3.25 g*), which did not 
solidify, and which decomposed on distillation.
2 :2:6-Trimethyl-4-phenyl-4-acetoxypiperidine (XL): 2:2:6-
Trimethyl-4-piperidone (5.0 g.) was reacted as before with 
phenylmagnesium bromide solution (50$ excess) and the 
mixture refluxed for 13 hours. Acetic anhydride (11.0 g . ;  
200$ excess) in ether solution was then added in the cold 
and the solution refluxed for a further 9 hours, then cooled 
and decomposed with ice and excess 6N hydrochloric acid*
The aqueous liquor was separated, basified with sodium 
hydroxide solution and extracted with chloroform. This 
extract, dried over anhydrdus sodium sulphate and evaporated, 
gave a basic oil (0.3 g.) distilling at 110-120°/2 m.m., and
a quantity of unreacted piperidone (0.7 g*). Prom the oil 
was isolated a very small quantity of colourless crystalline 
material, insoluble in ether, which crystallised from 
ethanol/ether in colourless prisms, m.p. 176-177° (decomp*), 
and whose composition is in agreement with its identifica­
tion as 2 ;2 ;6-trimethy1-4-phenyl-4-acetoxypiperidine acetate.
This acetate, dissolved in ethanol and treated with hydrogen 
chloride, gave a product which crystallised from ethanol/ 
ether in colourless prisms, m.p* 238-239° (decomp*), whose 
composition is in agreement with its identification as 
2 :2:6-trimethyl-4-pheny1-4-acetoxypiperidine hydrochloride.
C16H24°2N C1 requires : C, 64.5; H, 8.1; N, 4*7$
The remainder of the oil, which did not solidify, was con­
verted to the hydrochloride in ether solution, and the 
product crystallised from ethanol/ether in colourless prisms, 
m*p. 264-265° (decomp.)* This was identified by comparison 
with an authentic specimen and by analysis as 2 :2 :6-trimethyl- 
4-phenyl-ls2:5:6 (or 1 :2:3s6)-tetrahydropyridine hydro­
chloride :
Pound : C, 70*9; H, 8*3; N, 5.4 
°14H20N 01 re<luires : ° >  70*8» 8.4; N, 5*9$
Pound : C, 67.1; H, 8.1; 
C18H27°4N re£iuires : C, 67*3; H, 8.4;
Pound : C, 64.3; H, 7*9; N, 4-8
In another experiment, where a smaller excess ( 1 0 % )  
of acetic anhydride was used, and the time of refluxing 
after its addition reduced to 3 hours, the product obtained 
was an oil (3.5 g.) which distilled at 122-125°/3 m.m.
Prom this was isolated a few milligrams of a material which 
crystallised from acetone in colourless prisms, m.p. 223- 
224° (decomp.), whose composition is in agreement with its 
identification as 2 :2:6-trimethyl-4-phenyl-4-hydroxypiperidine 
acetate:
Pound : C, 69.2; H, 8.9; N, 5.2
C16H25^3N recluires 5 G > 68.8; H, 9.0; N, 5.0$ it 
comparison with a specimen prepared directly from 2 :2 :6-
trimethyl-4-phenyl-4-hydroxypiperidine confirmed this.
The acetate, dissolved in ethanol and treated with hydrogen
chloride, gave a product which crystallised from ethanol/
ether in colourless prisms, m.p. 244° (decomp.). This was
identified by comparison with an authentic specimen and by
analysis as 2:2:6-trimethyl-4-phenyl-4-hydroxypiperidine
hydrochloride:
Pound : C, 66.0; H, 8.7; N, 5.5
-^14^22® ^ ^  re(Iu:kres s 65*7; H, 8.6; N, 5.5$ L 
The remainder of the oil, by conversion to the hydrochloride 
and comparison with an authentic specimen, was proved to be 
mainly 2:2:6-trimethy1-4-pheny1-4-hydroxypiperidine.
81.
l-Aoetyl-2 ;2:6-trimethyl-4-phenyl-4-hydroxypiperidine (XXXIX) : 
2:2:6-Trimethyl-4-phenyl-4-hydroxypiperidine (0.25 g.) was 
refluxed with excess acetic anhydride (2.5 g.) for 5 minutes; 
the solution was then cooled, basified with sodium hydroxide 
solution and extracted with chloroform. The extract was 
washed with dilute hydrochloric acid to remove basic material, 
dried over anhydrous sodium sulphate and evaporated, giving 
an oil (0.25 g.) which solidified on standing. Crystallisa­
tion from 80/100° petroleum ether gave a colourless crystal­
line material which melted sharply at 121-122°: consistent
analyses, however, could not be obtained. From this 
material by fractional crystallisation from 80/100° petroleum 
ether was isolated l-acetyl-2 :2 : 6-trlmethyl-4-phenyl-4- 
hydroxypiperidine (0.1 g.), in colourless elongated prisms, 
m.p. 112-113°:
Pound : C, 73.2; H, 8.8; N, 5.1
C,„Ho_0„H requires : C, 73.6; H, 8 .8; N, 5.4$
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Ho other product could be isolated from the remaining 
material.
1 :2:2 ;6-Tetramethyl-4-pbenyl-4-hydroxypiperidine (XXXV):
2 :2:6-TrImethyl-4-phenyl-4-hydroxypiperidlne (2.0 g.) was 
heated with 40$ formaldehyde solution (2.0 g.) at 100°.
After 1 hour a vigorous reaction occurred and the whole mass
solidified. The solid was washed free from formaldehyde 
with water, dried at 100° and crystallised from light 
petroleum* 1 :2:2:6-Te tramethyl-4-phenyl-4-hydroxy­
piperidine formed colourless needles, m.p. 133-134°.
Found : C, 77.4; H, 9.7; N, 6.2
G15H230$r requires : C, 77.3; H, 9.9; N, 6.0$
The hydrochloride, prepared from the base In ether solution, 
crystallised from ethano3/©fcher 3n colourless prisms, 
m.p. 243-244° (decomp.).
| Found : C, 66.8; H, 8.9; N, 5.4
I C,,.Ho .0N Cl requires ; C, 66.8; H, 8.9; K, 5.2$ \
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The picrate, prepared from the base in ether solution, 
crystallised from acetic acid in yellow prisms, m.p. 230- 
231° (decomp.).
( Found : G, 54.8; H, 5.9; N, 11.8
C21H26°8N4 re<lulres 5 0, 54.6; H, 5.6; N, 12.1$
The hydrogen oxalate was unsatisfactory, apparently on 
account of dehydration of the alcohol.
1 :2:2:6-Tetramethyl-4-phenyl-4-hydroxypiperidine 
did not give a urethane derivative with phenylisocyanate, 
but dehydration occurred and the water eliminated reacted 
to form carbanilide•
l:2:2:6-Tetramethyl-4-phenyl-l:2:5:6 (or 1:2:5 :6)-tetrahydro- 
pyrldine (XXXVI or XXXVII; R » Me): 1 :2:2:6-Tetramethyl-
4-phenyl-4-hydroxypiperidine (0.5 g.) in ethanol (10 c.c.) 
was saturated with hydrogen chloride and heated at 80° for 
7 hours, during which time the solution was periodically 
resaturated with hydrogen chloride. The solution was then 
basified with sodium hydroxide solution and extracted with 
ether. The extract, dried over anhydrous sodium sulphate 
and evaporated, gave a brown, basic oil which did not 
solidify. This base was converted to the picrate in ethanol 
and 1 :2:2:6-tetramethy1-4-phenyl-1:2:5:6 (or 1:2:5:6)-tetra- 
hydropyridine picrate crystallised from ethanol in yellow
needles, m.p. 161-162° (decomp.)
j" Pound : C, 57.5; H, 5.4; N, 12.6
1 C21H24°7^4 re(lu^res : c> 57.6; H, 5.4; N, 12.6$
Attempted esterificatlon of 1:2:2:6-tetramethyl-4-pheny 1-4-
hydroxy piperidine (XXXV).
a). With acetic anhydride. The acetylation of 1:2:2:6- 
tetramethyl-4-phenyl-4-hydroxypiperidine with acetic an­
hydride was investigated over a wide range of conditions.
The alcohol was unaffected when treated with acetic anhydride 
alone or .diluted with benzene, for 1 hour at temperatures up 
to 100°. Acetic anhydride with pyridine, sodium acetate or 
a trace of concentrated sulphuric acid as catalyst caused
dehydration of the alcohol to a varying extent, depending on 
the severity of the conditions : only unchanged alcohol and
(sometimes) the dehydration product could be isolated from 
the mixed product of the reaction.
b)• With acetyl chloride. Acetyl chloride in the cold, with 
or without an inert diluent (ether, benzene) brought about 
complete dehydration of the alcohol within 48 hours. In
the presence of a basic catalyst (pyridine, dimethylaniline) 
acetyl chloride gave a mixed product similar to that obtained 
above.
c). acetic anhydride on the Grignard complex. A solution 
of ethylmagneslum bromide was prepared in the usual way from 
magnesium (0*25 g.), ethyl bromide (1.1 g.) and ether (5 c.c#), 
refluxed for 2j hours. 1 :2:2:6-Tetramethy1-4-phenyl-4- 
hydroxypiperidine (0.2 g.) in ether solution was added slowly 
in the cold to 2 c.c. of this solution, and the mixture re- 
fluxed for ij hours, when a colourless solid separated.
The mixture was then cooled in ice while acetic anhydride 
(2.0 g.) was added dropwise with shaking; further precipita­
tion occurred. The mixture was refluxed gently for 30 
minutes, cooled and decomposed by pouring on to ice/acetic 
acid. No solid separated. The aqueous layer was separated, 
washed with ether, basified with sodium carbonate and ex­
tracted with chloroform: the extract was dried over anhydrous
sodium sulphate and evaporated, giving a brown oil (0.2 g.). 
Prom this oil was isolated a few milligrams of an ether- 
insoluble, deliquescent solid. On account of its deliques­
cence this product could not be further investigated, but 
its properties indicated its identification as a salt of 
one of the basic products appearing in the reaction- The 
remaining oil was a mixture from which no identifiable 
material could be isolated.
In another experiment, after the addition of acetic 
anhydride to the solution containing the Grignard complex 
of the alcohol, the reaction mixture was allowed to stand 
at room temperature for lj hours, then decomposed as before. 
In this case the only product isolated was unchanged alcohol 
(.05 g.), isolated as the picrate and identified by com­
parison with an authentic specimen. The remainder of the 
product was a mixed oil from which no Identifiable product 
could be isolated.
Section 3.
The Decahydroisoquinolines•
1-Acetylcyclohex-1-ene (LXIV) : 1-Acetylcyclohex-1-ene was
prepared from cyclohexene and acetyl chloride by the Friedel-
Crafts* reaction in carbon disulphide in the presence of
stannic chloride, followed by elimination of hydrogen
chloride from the intermediate chloro-ketone by refluxing
61 62with diethylaniline 9 , and was characterised by the
o 61semicarbazone, m.p. 220 (decomp.). (Darzens records a
o .
melting-point of 220 for the seifaicarbazone.)
1-Acetyjcyclohex-1-ene (8.0 g.) was added to a 
solution of hydroxylamine hydrochloride (5.0 g.) and 
potassium hydroxide (3.0 g.) in water (13 c.c.): ethanol
was added until a clear solution was obtained and the 
mixture refluxed for 1 hour. Further potassium hydroxide 
solution was added to neutralise the mixture and refluxing 
continued for a further 3 hours. The mixture was then 
poured into water and made slightly acid with dilute hydro­
chloric acid. The solid (3.0 g.) which separated crystal­
lised from aqueous methanol, giving 1-acetylcyclohex-l-ene
* Ooxime (2.1 g.) as colourless needles, m.p. 61-62 •
Found: C, 69.3; H, 9.3; N, 9.9
CoH__0N requires: C, 69.1; H, 9.1; N, 10*1$
L o lo J
In another experiment, where acety Icyclohexene was 
heated at 100° for 4 hours with hydroxylamine hydrochloride
in pyridine solution, the same product was obtained.
61 63(Darzens and Wallach respectively record the melting
point of the oxime as 90° and 99°.) This oxime was
irradiated with ultra-violet light for 3 hours without
effect.
< -2-Acetylcyolohexylphenylacetonitrile (L) : To a mixture
of 1-acetyl eye lohex- 1-ene (20 g.) and phenylacetonitrile 
(20 g.) was added slowly a solution of sodium ethoxide 
(from 4.0 g. sodium and BO c.c. dry ethanol): after stand­
ing at room temperature for 4 hours the mixture was poured 
into 10$ hydrochloric acid (250 c.c.), and the resulting 
-2-aoetyleyolohexylphenylacetonitrile (22.5 g.) separated
overnight and crystallised from ethanol in colourless prisms,
O 58m.p. 119-120 • (Barr and Gook record a melting point of
120° for < d -2-acetyloyelohexylphenylaoetonitrile.) Treated
with semicarbazide hydrochloride in aqueous pyridine this
gave the semicarbazone, which crystallised from ethanol in
G.olourless prisms, m.p. 229-230° (decomp*).
! ! !
Found: 0, 68*4; H, 7.4; N, 18.8
G H ON requires: C, 68.5; H, 7.1; N, 18.8#
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After separation of the < * . -2-acetylcyclohexyIphenylaceto-
nitrile from the reaction product a quantity of oil remained- 
When a portion of this was treated with semicarbazide hydro­
chloride in aqueous pyridine a small yield of the above 
acetylcyclohexylphenylacetonitrile semicar bazone was isolated. 
On dilution of the pyridine solution with water a small 
yield of another colourless material was obtained, which
i
melted at ca. 175° after crystallisation from aqueous 
ethanol: this material was difficult to purify and was not
identified.
4-Phenyl-l-methyl-2-ethyldecahydroisoquinollne (LI): -2-
Acetylcyclohexylphenylacetonitrile (10.4 g.) In ethanol 
(500 c.c.) was hydrogenated at 200° and 175 atm. for 2 hours, 
with copper chromite catalyst64 (3.0 g.; prepared by 
Ignition over a free flame). The catalyst was filtered off, 
and the solution evaporated under reduced pressure; the 
oil obtained was dissolved in ether and extracted with dilute 
hydrochloric acid, the acid solution basified with sodium 
hydroxide solution containing some ammonia to prevent pre­
cipitation of residual chromium salts, and extracted with 
ether - The ether extract was dried over anhydrous sodium 
sulphate and evaporated, giving a colourless oil (9.0 g.) 
distilling at 166°/2»5 m.m. This base in ether solution 
was converted to the picrate, which was separated by 
fractional crystallisation from ethanol Into two isomeric
4-phenyl-l-methyi-2-ethyldecahydrolsoqulnollne picrates ;- 
A) long yellow needles,m.p. 178-179° 
r Pound : G, 59.3; H, 6.4; N, 11.3
Prom each picrate was obtained the corresponding isomer of 
the base, 4-phenyl-l-methyl-2-ethyldecahydroisoquinoline
mixed base was unsuccessful as the product was deliquescent.
isolated indicated that the isomeric bases were present in 
the original mixed product in the ratio A : B ® 2-3 s 1 
•pproximately •
4-Phenyl- 1-metbylisoquinoline; The mixed 4-phenyl-l-methyl-
2-ethyldecahydroisoquinoline (1.5 g.) was heated with
G24H30°7N4 re(lulr0s : C, 59.3; H, 6.2; N, 11.5$ ,
and B) small yellow needles, m.p. 209-210° (decomp,) 
j' Pound : C, 59.5; H, 6.2; N, 11.7
1 C24H30°7N4 re(ltlires 5 G, 59.3; H, 6.2; N, 11.5$ L 
A) colourless oil, b.p. 155°/2 m.m.
1
Pound •*• C, 84.0; H, 10.3; N, 5.4
I
C H N requires : C, 84.0; H, 10.5; N, 5.4 i 
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and B) colourless oil, b.p. 136°/1. m . m .
Found : C, 84.2; H, 10.3; N, 5*5 
^18^27^ requires : C, 84-0; H, 10.5; N, 5.4$ 
An attempt to prepare the hydrochloride of the
The relative amounts of the isomeric picrates
palladium catalyst (-15 g.) at 300-320° till evolution of 
gas became negligible and practically the theoretical 
amount had been collected (8 hours). The product was then 
extracted with ether, the ether evaporated and the product 
distillediat 150-154°/l m.m. to give a light brown oil 
(1*25 g«). This was converted to the picrate and after 
crystallisation from ethanol and benzene alternately gave 
4-phenyl-1-methylisqquinoline picrate in small yellow 
needles, m.p. 229-230° (decomp.).
Found : C, 59.2; H, 3.6; N, 12.8
C H O N  requires : C, 58.9; H, 3*6; N, 12.5$
i 22 16 7 4 '
(Krabbe®6 records a melting point of 206° for the picrate 
of 4-phenyl-l-methylisoquinoline.)
From the picrate was obtained the base, a pale 
yellow oil distilling at 140° (bath)/l m.m., which solidi­
fied on standing and on crystallisation from petroleum 
ether gave 4-phenyl-l-methylisoquinoline 3n colourless 
elongated prisms, m.p. 78-79°.
j” Found : C, 88.0; H, 6.1; N, 6.4 ~
j requires : C, 87.7; H, 6.0; N, 6.4$ .i
(Krabbe, loc.cit., records a melting point of 79° for 
4-phenyl-l-methylisoquinoline).
An attempt to prepare the methiodide of this base 
was unsuccessful as the product was unstable.
4-Phenyl-l:2-dimethyldecahydroisoquinoline (LII; H « Me) : 
ot  -2-Acetylcyclohexyl^phenylacetonltrile (10.0 g.) in 
methanol (500 c.c.) was hydrogenated at 200° and 190 atm. 
for 4 hours with copper chromite catalyst (3.0 g.). The 
basic product was extracted as before, and distilled at 
150-155°/2 m.m#, giving a colourless oil (7.0 g#) and leav­
ing a non-volatile residue (2.0 g.) which was not investigated. 
The picrate of the oil was prepared in ether, and by fraction­
al crystallisation from ethanol was separated into two 
isomeric 4-phenyl-1 :2-dimethyldecahydroisoQuinollne picrates ;- 
A) small yellow needles, m.p. 176-177°
Pound : C, 58.6; H, 6.1; N, 12.1
C23H28°7N4 recluires : G> 58.5; H, 5.9; N, 11.9$
and B) long yellow needles, m.p. 205-206° (decomp.) 
j' Pound : C, 58.7; H, 5.7; N, 12.1
1_C23H28°7N4 reclulres : 58.5; H, 5.9; N, 11.9$
Prom each picrate was obtained the corresponding isomer of 
the base, 4-phenyl-l;2-dime thyldecahydroisoqulnoline 
A) colourless oil, b.p. 152°/l.5 m.m.
r Pound : C, 84.0; H, 10.3; N, 5.4
C H N requires : C, 84-2; H, 10.1; N, 5.7$
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and B) colourless oil, b.p. 141°/l*5 m.m.
[ Pound : C, 84.0; H, 10.1; N, 5.8
C17H25N requires : C, 84.2; H, 10.1; N, 5.7$
The relative amounts of the isomeric picrates 
isolated indicated that the isomeric bases were present 
in the original mixed product in the ratio A : B = 1 2 1 
approximately.
4-Phenyl-1 -methy 1 -2-n-propyldecahydroisoquinoline (LII;
R = n-Pr) : oC-2-Acetylcyclohexylphenylacetonitrile
(15.0 g.) in n-propanol (500 c.c.) was hydrogenated at 200° 
and 155 atm. for 2 hours with copper chromite catalyst (4*5 g. 
The basic product was isolated as before, and distilled at 
173-178°/3 m • m. giving a colourless oil (15.4 g.)« This 
base In ether solution was converted to the picrate, which 
was separated by fractional crystallisation from ethanol 
into two isomeric 4-pheny 1-1-methyl-2-n-propyldecahydro- 
isoquinoline picrates:
A) yellow needles, m.p. 148-149° 
f Pound : G, 60.0; H, 6.4; N, 11.5
i C 2 5 H 3 2 ° 7 N 4  reclu^res : C, 60-0; H, 6.4; N, 11*2$ (
and B) yellow needles, m.p. 184-185° (decomp.)
Pound : G, 60.3; H, 6.2; N, 11.2
G25H32°7N4 re(luires : C, 60.0; H, 6.4; N, 11.2$
Prom each picrate was obtained the corresponding isomer of 
the base,' 4-phenyl-l-methyl-2-n-propyldecahydroisoqu*noline; 
A) colourless oil, b.p. 147-149°/0.8 m.m.
Found : C, 83.9; H, 10.3; N, 4*8 
CigH2gN requires : C, 84*1; H, 10.7;, N, 5.2$
and B) colourless oil, b.p. 175° (bath)/0*7 m.m. 
j* Pound : C, 83.9; H, 10.5; N, 5*0
lC19H29N re(l'ui:res 5 C, 84.1; H, 10.7; N, 5.2$
The relative amounts of the isomeric picrates 
isolated indicated that the isomeric bases were present 
in the original mixed product in the ratio A : B = 10 : 1 
approximately •
«<■-2-Ace tylcyclohe:xylphenylaoetic acid (LVIII) s *£-2- 
Acetylcyclohexylphenylacetonitrile (4.0 g.) was refluxed 
for 3 hours with potassium hydroxide (15.0 g.) in water 
(30 c.c.) and ethanol (40 c.c*). The solution was then 
diluted with water (30 c.c.), washed with ether, acidified 
with dilute hydrochloric acid and again extracted with 
ether. This extract was dried over anhydrous sodium sul­
phate and evaporated, giving a yellow oil (1.5 g.) which 
solidified on standing, and on crystallisation from 80/100°
petroleum ether gave d  -2-ace tylcyclohexylpheny lace tic acid
o
in colourless prisms, m.p. 146-147 .
j~ Pound : C, 73.7; H, 7.8
! C16H20°3 retires s C, 73.8; H, 7.7#
A quantity of non-aeidic material (0-4 g.) was also 
isolatedr  which contained nitrogen and crystallised from 
80/100° petroleum ether in colourless plates, m.p. 222-223°.
Analysis supports the identification of this material as 
4-phenyl-1-methyl-5 :6:7 :8:9:10-hexahydro-5-isoquinolone.
Pound : C, 79.7; H, 8.0; N, 5.9
c10Hig°N requires : C, 79.7; H, 7.9; N, 5.8$ .
Ethyl- -2-acetyIcyclohexylphenylacetate (LV): <*-2-
Ace ty Icy clohexylpheny lace tonitrile (10.0 g.) was refluxed 
for 17 hours with a mixture of 95$ ethanol (20 g.) and 
concentrated sulphuric acid (20 g.). The solution was 
then cooled and diluted with water (50 c.c.), the ester 
extracted with ether, the extract washed with sodium 
carbonate solution, dried over anhydrous sodium sulphate 
and evaporated, giving ethyl -2-acetylcyclohexylphenyl- 
acetate, a colourless oil, b.p. 166-168°/l m.m. (6.0 g.).
Pound : 0, 75.2; H, 8.3
G18H24°3 re<lulre3 ! c > 75.0; H, 8.3$
A portion of this ester (0.75 g.) was hydrolysed by 
refluxing for 3 hours with a solution of potassium hydroxide 
(2-0 g.) in ethanol (4 c.c.) and water (2 c.c.). The 
solution was then diluted with water (15 c.c.), washed with 
ether, acidified with dilute hydrochloric acid and again 
extracted with ether. This extract was dried over anhydrous 
sodium sulphate and evaporated, giving a pale yellow solid 
which distilled at 190-200° (bath)/l m.m., and crystallised 
from petroleum ether in colourless prisms, m.p. 146-147°
(0.35 g.) . B y  comparison with an authentic specimen this 
was identified as -2-acetyloyclohexylphenylacetlc acid, 
thus confirming the identity of the ester from which it was 
obtained*
Oxime of ethyl -2-ace ty Icy clohexylphenylacetate (LVX) %
Ethyl < k  -2-acetyIcyclohexyIphenylacetate (5.0 g.) was re- 
fluxed with hydroxylamine hydrochloride (2.5 g.) and 
sodium acetate (5.0 g#) in aqueous alcoholic solution for 
3 hours. The mixture was then poured into water and the 
product extracted with ether, the extract dried over an­
hydrous sodium sulphate and evaporated, giving an oil 
(5*0 g*) idiich did not solidify. A  similar oily product 
was obtained when the ester was treated with bydro^laiilne 
hydrochloride la pyridine solution at 100°.
hydrogenation of the oxime of ethyl ^ -2-acetylsyelche3grl-
pjjenylacetete {3L¥Xj.
The oil obtained above (2.5 g.) in methanol (1©© c.c. 
-was hydrogenated at 200° and M 5  ate# for 2 hours using 
copper chromite catalyst (1*0 g*J. Tbs catalyst mss then 
filtered off and the alcoholic solution evaporated giving a 
yellow oil which partly solidified. This was dissolved in 
dilute hydrochloric acid, washed w t t f a  ether, the solution 
hasified with dilate sodium hydroxide sotetion, and sg&Sm
extracted with ether. The extract was dried over anhydrous 
sodium sulphate and evaporated. The basic product on dis­
tillation gave two fractions:-
a) a colourless oil (0.1 g.), b.p. 146° (bath)/l m.m. This
oil in ether solution was converted to the picrate (0*15 g.),
m.p. 189-193° (crude), which crystallised from ethanol in
o , *
yellow needles, m*p. 202-203 (decomp.), and was identified 
by comparison with an authentic specimen as 1 0  1 4-phenyl- 
1:2-dimethyldecahydroisoquinoline picrate. No trace of
the corresponding 1 * isomer was found j
b) a colourless solid (0*15 g*), which was separated by 
fractional crystallisation from 80/100° petroleum ether 
into two isomeric products whose composition supports their 
identification as isomeric 4-phenyl-1-methyldecahydro-3- 
lsoqulnolones:
1) Colourless needles, m.p. 168-169° (.02 g.)
| Pound s C, 79.0; H, 8.6; N, 5.4
Ci6H2i°N requires : C, 79.0; H, 8.6q N, 5.7#
o2) Colourless needles, m.p. 180-181 (.05 g.)
Pound : C, 79.3; H, 8.5; N, 5.9
G16H210N requires : C, 79.0; H, 8.6; N, 5.7$
Condensation of 1-acetyloyclohex-l-ene with ethyl phenylacetate 
(LXII3 LXIII).
A  solution of sodium ethoxide (from 6 g. of sodium
and 120 c.c• of ethanol) was added slowly to a mixture of 
1-acetylcyclohex-l-ene (30 g.) and ethyl phenylacetate 
(26 g.): little reaction was apparent in the cold, so the
mixture was refluxed for 5 hours• The mixture was then 
cooled and poured into 10$ hydrochloric acid (375 c.c.).
The solid product which separated on standing overnight was 
filtered off and washed with petroleum ether which removed 
a quantity of oil, leaving a yellow powder (33 g.)« By 
fractional crystallisation from aqueous ethanol this was 
separated into two main products:
a) small colourless needles, m.p. 197-198° (from aqueous
ethanol)
Found: C, 79.0; H, 7.5
C16H18°2 requires: C, 79.3; H, 7.4$
and b) colourless prisms, m.p. 169-170° (from 80/100° petroleum
ether). |
if
Pound: C, 79.0; H, 7.4 ’ \
!iI!
c 16H18°2 re<iuir©s: 0, 79.3; H, 7.4$ .
These were present in the original mixture in the 
approximate proportions a : b « 1 : 10. The petroleum 
ether washings from the reaction product contained an oil 
from which no identifiable material could be isolated.
Microhydrogenation of these two products over Adams1 
catalyst in acetic acid, assuming a molecular weight of 242 
in each case, resulted in hydrogen absorption equivalent to
6.05 double bonds per molecule in the case of a), and 
5.9 in the case of b ) .
The oxime of product a) was obtained by treating 
the material (1-0 g.) in pyridine (20 c.c.) with a solution 
of hydroxylamine hydrochloride (2.0 g.) in the minimum 
quantity of water, and allowing the mixture to stand at 
room temperature for 48 hours, then diluting with water.
A gum separated, which solidified on prolonged standing 
(3 weeks). Washing with benzene removed a quantity of red 
oil from this, leaving a colourless solid (0.4 g.) which 
crystallised from aqueous ethanol to give the dioxime in 
colourless needles, m.p. 124-125° (decomp.):
Found : C, 69.0; H, 7.6; N, 9.9
C H 0 N requires : C, 70.6; H, 7.4; N, 10.3$ «
i u  & U  <5 6
The oxime of product b) was obtained similarly by treating 
a solution of b) (0.2 g.) in pyridine with a concentrated 
aqueous solution of hydroxylamine hydrochloride (0.2 g.) 
and allowing the mixture to stand at room temperature for 
48 hours. On dilution of this solution with water a 
colourless solid (0*2 g.) separated, which crystallised from 
aqueous dshanol to give the dioxime in small colourless 
needles, m.p. 218-219° (decomp.):
Found : C, 70.6; H, 7.4; N, 9.9
C16H20°2N2 re(luires : C ' 70'6> E > 7#4> 10.3$
Hydrogenation of this dioxime - b) at 135-145° and 130 atm. 
in ethanol over copper chromite catalyst resulted in de­
composition of the dioxime without the formation of any 
basic product.
1-Pheny lace ty Icy c lohe x- 1-ene (LXIV) : A mixture of cyclo-
hexene (210 g.) and phenylacetyl chloride (100 g.; pre­
pared from phenylacetic acid and distilled at 92°/lO m.m.) 
was added slowly with stirring to a solution of stannic 
chloride (500 g.) in carbon disulphide (1200 g.), the tem­
perature being maintained below -5°. After the addition 
was complete the mixture was allowed to stand for 2 hours 
at -5°, then overnight at room temperature. Decomposition 
of the intermediate chloroketone and isolation of the pro­
duct were then carried out in the usual way (Gook6*^) to 
give 1-phenylacetylcyclohex-l-ene (69 g.), b.p. 150-154°/4 m. 
which was characterised by the semicarbazone, m.p. 169-170° 
(Cook, loc.cit., records a melting point of 168-169° for 
the semicarbazone of 1-pheny lace tylcyclohex-l-ene).
Condensation of 1-phenylacetylcyclohex-l-ene with ethyl
cyanoac e tate (LXVIII).
A.solution of sodium ethoxide (from 2.5 g. of sodium 
and 50 c.c. of ethanol) was added slowly with stirring to a
mixture of 1-phenylacetylcyclohex-l-ene (10 g.) and ethyl 
cyanoacetate (5.5 g.), and the mixture allowed to stand at 
room temperature for 4i hours. The mixture was then poured 
into 10$ hydrochloric acid, and a solid product separated 
on standing overnight. This was washed rapidly with ether, 
which removed a quantity of oil, and crystallised from 
benzene in colourless prisms (6.0 g.}, m.p. 199-200°:
Pound : C, 76.2; H, 6.3; N, 5.0
G17h1 7 ° ^  re<luires : G> 76.4; H, 6.4; H, 5.2$ ,
This product did not give an oxime, semicarbazone
or 2 :4-dinitrophenylhydrazone. It gave a yellow colour
with ferric chloride solution; was moderately soluble in 
dilute sodium carbonate solution from which it was precipi­
tated on addition of dilute hydrochloric acid; and was not 
hydrolysed when heated at 55° for 3 hours with aqueous 
alcoholic potassium hydroxide solution. An ethoxyl 
determination gave a negative result.
Treatment with acetic anhydride in pyridine for 
3^ hours at room temperature gave a diacetyl derivative, 
which crystallised from aqueous ethanol 3n colourless prisms, 
m.p. 129-130°:
Found : C, 72.1; H, 6.0; N, 4.1
G H 0 N requires : C, 71.8; H, 6.0; N, 4*0$ ,
L 21 21 4
Condensation of malonamlde with 1-phenylacetylcyclohex-l-ene 
(LXX).
Malonamide was prepared from diethylmalonate and
68concentrated aqueous ammonia , and crystallised from 
ethanol in colourless prisms, m.p. 170°. This (6.75 g.;
10$ excess) was dissolved in dry ethanol (300 c.c.) with 
heating, 1-phenylacetylcyclohex-l-ene (12 g.) was added to 
the hot solution, and then a solution of sodium ethoxide 
(from 1.7 g. of sodium and 30 c.c. of ethanol) was added 
dropwise with stirring. The colour of the solution 
darkened immediately and a little solid precipitated. The 
solution was refluxed for 12 hours, during which time 
evolution of ammonia occurred. The mixture was then 
evaporated to approximately 50 c.c., poured into excess 10$ 
hydrochloric acid (200 c.c.) and allowed to stand overnight* 
The solid which separated was filtered, washed with ether 
and then with a little warm ethanol which removed a 
quantity of oil, giving an almost colourless solid (6.8 g.). 
This crystallised from ethanol to give 1-benzyl-5:6:7:8:9:10 
hexahydro-3-isoquinolone-4-carboxyamide in colourless prisms 
m.p. 257-258° (decomp.)•
Pound : 0, 71.6; H, 7.0; N, 9.8 
C17H20G2N2 re<luires : 71.8; H, 7.0; N, 9.9$],
The washings from the reaction product yielded an 
oil from which only a little unchanged malonamide could be 
isolated*
l-Benzyl-5:6:7:8;9:10-hexahydro-5-isoquinolone-4-carboxylic 
acid (LXXI): l-Benzyl-5:6:7 :8:9:10-hexahydro-3-isoquiriolone-
4-carboxyamide (2.0 g.) was dissolved in 40$ sulphuric acid 
(130 c.c.) at 100°, and with constant stirring sodium 
nitrite (1.0 g.) in water (10 c.c.) was introduced very 
slowly under the surface of the hot solution by means of a 
capillary. An extremely vigorous reaction occurred with 
copious evolution of gas. After the addition was complete
the solution was heated for a further 5 minutes till evolu­
tion of gas ceased, then was cooled and diluted with water 
(ca. 200 c.c.). The solid which separated was dissolved 
in dilute sodium carbonate solution, the solution filtered 
to remove a little dark residue, and then acidified with 
dilute hydrochloric acid to give a pale yellow solid (1*8 g.). 
This crystallised from aqueous ethanol to give 1-benzyl- 
5 s6 s7:8:9:10-hexahydro-5-isoquinolone-4-car boxy lie acid in 
colourless plates (or needles), m.p. 204-205° (decomp#)
Pound : C, 71.9; H, 6.2; N, 5.0
C H O H requires : C, 71.6; H, 6.7; N, 4.9$
17 19 o
l-Benzyl-5:6:7 :8 :9 :10-hexahydro-3-isoquinolone (LXXII): 
l-Benzyl-5 :6 ;7:8:9:10-hexahydro-3-isoquinolone-4-carboxylic 
acid (1.82 g.) was heated at 210°. The solid melted, a 
vigorous evolution of gas occurred, and after approximately 
15 minutes the mass resolidified. The product crystallised 
from ethanol to give 1-benzyl-5;6:7:8:9:10-hexahydro-5- 
isoquinolone (1*3 g.) in colourless needles, m.p. 244-245° 
(decomp.)
Pound : C, 80.6; H, 7.1; N, 6.1
requires : C, 79.7; H, 7.9; N, 5.8$
JLo J.9
1-Benzyldecahydroisoquinoline (LXXIII): l-Benzyl-5:6:7 :8:9:10-
hexahydro-3-isoquinolone (0.5 g.) was dissolved in dry 
n-butyl alcohol (10 c.c.) at the boiling point, and to this 
hot solution was added sodium (0.76 g.) all at once; re- 
fluxing was then continued for 30 minutes. The pasty 
mixture was washed with water (3 c.c.) and then acidified
with dilute hydrochloric acid (10 c.c.). The alcohol was
then evaporated, water being added as required to maintain 
the volume of the aqueous solution. The aqueous solution 
was then extracted with ether, and from this extract was 
obtained a quantity (0.3 g.) of non-basic oil. The aqueous 
solution was then basified with sodium hydroxide solution, 
extracted with ether, the extract dried over anhydrous 
sodium sulphate and evaporated, giving a basic oil (0.1 g.).
This appeared to decompose slightly on distillation at 
130-140° (bath)/0.8 m.m., and was converted to the hydrogen 
oxalate in ether solution. Crystallisation from ethanol/ 
ether gave 1-benzyldecahydroisoquinoline hydrogen oxalate 
in colourless needles, m.p. 161-162° (decomp.)
f Pound : C, 68.1; H, 7.3; N, 4.6
[ g iqH2504H requires : C, 67.7; H, 7.8; N, 4«4$
Condensation of cyanoacetamide with 1-phenylaoetylcyclohex-
1-ene (LXXIV).
Cyanoacetamide was prepared from ethyl cyanoacetate 
and concentrated aqueous ammonia68, and ciystallised from 
ethanol in colourless prisms, m.p. 119°. This (3.5 g.;
10$ excess) was dissolved in dry ethanol (75 c.c.) with 
heating, 1-phenylacetylcyclohex-l-ene (7.5 g.) was added 
to the hot solution and then a solution of sodium ethoxide 
(from 1.1 g. of sodium and 25 c.c. of ethanol) was added 
dropwise with stirring. The colour of the solution darkened 
immediately and some solid precipitated. The solution was
refluxed for 7 hours, during which time evolution of ammonia 
occurred. The mixture was then evaporated to approximately 
50 c.c., poured into 10$ hydrochloric acid and allowed to 
stand overnight. The solid which separated was filtered, 
washed1 with ether and then with a little warm ethanol which
removed a quantity of oil, giving a cream powder (2.2 g.)« 
This crystallised from ethanol to give jl -2-phenylacetyl- 
cyclohexylcyanoacetamide in colourless needles, m.p. 247- 
248° (decomp.)
f Pound : C, 71.9; H, 7.1; N, 10.1
[C17H20G2N2 re(lulres : c » 71*8; H, 7.0; N, 9.9$.,
The washings from the reaction product yielded an
oil, from which a further quantity (0.7 g.) of the above 
product was precipitated on addition of ether. The re­
maining oil was distilled, giving a first fraction distilling 
at 90-94° / l , identified as unchanged phenylacetylcyclo- 
hexene, and a second fraction distilling at 120-140°/l m.m. 
with some decomposition, which appeared to be a mixture.
Prom the non-volatile residue a further small quantity of 
o L -2-phenylacetylcyclohexylcyanoacetamide was isolated.
Reaction of ^-2-phenylacetylcyclohexylcyanoacetamide with 
sodium nitrite and sulphuric acid (LXXI).
< < -2-PhenylacetylcycIdhexylcyanoacetamide (0.3 g.) 
was dissolved in 50$ sulphuric acid (50 c.c.) at 140°, and 
sodium nitrite (0.2 g.) in water (2 c.c.) was introduced 
very slowly, with constant stirring, under the surface of 
the hot solution by means of a capillary. An extremely 
vigorous reaction occurred with copious evolution of gas.
After the addition was complete the solution was heated for 
a further 5 minutes till evolution of gas ceased, then 
cooled and diluted with water (ca. 150 c.c#). The solid 
which separated was dissolved in dilute sodium carbonate 
solution, and a quantity of insoluble material filtered off. 
This material (0.1 g.) was identified by comparison with an 
authentic specimen as unchanged ^-2-phenylacetylcyclo- 
hexylcyanoacetamide. The sodium carbonate solution was 
acidified with dilute hydrochloric acid, giving a pale 
yellow solid (0.15 g.) which crystallised from ethanol in 
colourless plates, m.p. 204-205°, and was identified by 
comparison with an authentic specimen as 1-benzyl-5:6:7:8:9:10- 
hexahydro-3-isoquinolone-4-carboxylic acid.
A portion of the above acid was heated at 210°, when 
it melted, evolution of gas occurred, and after approximate­
ly 15 minutes the mass resolidified. The product crystallised 
from ethanol in colourless needles, m.p. 244° (decomp.), and 
was identif ied by comparison with an authentic specimen as 
l-benzyl^-5:6 s7 58:9 slO-hexahydro-5-isoqulnolone, thus con­
firming the identity of the acid.
107.
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S U M M A R Y .
Synthetic Analgesics and Antispasmodics.
Three types of compound were investigated, the 
1 :4-bisdialkylaminoalkylnaphthalenes, certain 4-phenyl- 
4-hydroxypiperidines and a number of substituted deca- 
hydroisoquinolines.
In order that a preliminary estimate might be 
made of the antispasmodic and analgesic potentialities 
of the 1 :4-bisdialkylaminoalkylnaphthalene type of 
structure, three compounds of this type, 1 :4-bisdiethyl- 
aminomethylnaphthalene, 1:4-bisisothiocarbamidomethyl- 
naphthalene and 1 :4-bis-N-piperidylmethylnaphthalene were 
prepared by condensation of 1 :4-bischloromethylnaphthalene 
with the appropriate base, and were submitted for testing 
in the form of the hydrochlorides. Reports on the first 
two of these indicate that, while the antispasmodic 
activity is slight, they possess an analgesic potency of 
the same order as that of pethidine. This is a new class 
of compound to show pronounced analgesic activity.
2 :2:6-Trimethyl- and 1:2:2:6-tetramethy1-4-pheny1- 
4-hydroxypiperidine were prepared with a view to investigat­
ing the therapeutic effect of nuclear alkyl substituents 
in the 4-phenyl-4-hydroxypiperidine esters, which are known
to be potent analgesics. Mesityl oxide was condensed 
with ammonia to form 4-amino-4-methylpentan-2-one (di- 
acetonamine), which then condensed with acetal to give 
2 :2:6-trime thyl-4-piperidone (vinyldiacetonamine);. treat­
ment of this with phenylmagnesium bromide and decomposition 
of the resultant complex gave 2 :2:6-trimethyl-4-phenyl- 
4-hydroxypiperidine, from which 1 :2:2:6-tetramethy1-4- 
phenyl -4 -hydroxy piperidine was obtained by methylation 
with formaldehyde. The ease with which these piperidols 
underwent dehydration, however, rendered the preparation 
of the desired esters impracticable, though some estimate 
of the effect of the substituents may be obtained from the 
piperidols themselves, which were submitted for testing 
in the form of the hydrochlorides - A number of related 
compounds prepared in the course of this work are also 
described.
On the model of the octahydroisoquinoline portion 
of the morphine molecule a series of N-alkyl-4-phenyl-l- 
methyldecahydroisoquinolines was prepared for testing 
for analgesic activity. -2-Ace ty Icy clohexylphenyl -
acetonitrile, prepared by the Michael condensation of 
Ir-acetylcyclohex-l-ene and phenylacetonitrile, underwent 
reductive-cyclisation when hydrogenated in alcohol solution
over copper chromite catalyst to yield two stereoisomeric 
N-alkyl-4-phenyl-1-methyldecahydroisoquinolines, the 
nature of the N-alkyl group depending on the alcohol used 
as solvent. The N-methyl, N-ethyl and N-n-propyl compounds 
were prepared and submitted for testing. The similar 
reductive-cycli sat ion of the oxime of oc -2-ace tylcyc lo-
hexyI*phenylacetate was also investigated, and the method 
was extended in a modified form to the synthesis of 
1-benzyldecahydroisoquinoline.
